Menu
 
Research menu
Jump to menu

Publications:  Prof Stephen Duffy

Quaife SL, Ruparel M, Dickson JL, Beeken RJ, McEwen A, Baldwin DR, Bhowmik A, Navani N et al.(2020). Reply to Wilson: Improving Lung Cancer Screening Uptake. Am J Respir Crit Care Med vol. 202, (8) 1193-1194.
10.1164/rccm.202005-1699LE
https://qmro.qmul.ac.uk/xmlui/handle/123456789/65635
Ruparel M, Quaife SL, Dickson JL, Horst C, Tisi S, Hall H, Taylor M, Ahmed A et al.(2020). Lung Screen Uptake Trial: Results from a single lung cancer screening round. Thorax vol. 75, (10) 908-912.
10.1136/thoraxjnl-2020-214703
https://qmro.qmul.ac.uk/xmlui/handle/123456789/66356
Duffy SW, Vulkan D, Cuckle H, Parmar D, Sheikh S, Smith RA, Evans A, Blyuss O et al.(2020). Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. The Lancet Oncology vol. 21, (9) 1165-1172.
10.1016/S1470-2045(20)30398-3
Muratov S, Canelo-Aybar C, Tarride JE, Alonso-Coello P, Dimitrova N, Borisch B, Castells X, Duffy SW et al.(2020). Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators. BMC cancer vol. 20, (1)
10.1186/s12885-020-07289-z
Plackett R, Kassianos AP, Kambouri M, Kay N, Mylan S, Hopwood J, Schartau P, Gray S et al.(2020). Online patient simulation training to improve clinical reasoning: A feasibility randomised controlled trial. BMC Medical Education vol. 20, (1)
10.1186/s12909-020-02168-4
https://qmro.qmul.ac.uk/xmlui/handle/123456789/66358
Chapman D, Poirier V, Vulkan D, Fitzgerald K, Rubin G, Hamilton W, Duffy SW, ACE MDC projects(2020). First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer. Br J Cancer vol. 123, (5) 722-729.
10.1038/s41416-020-0947-y
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67124
Manchanda R, Sun L, Patel S, Evans O, Wilschut J, Lopes ACDF, Gaba F, Brentnall A et al.(2020). Economic evaluation of population-based brca1/brca2 mutation testing across multiple countries and health systems. Cancers vol. 12, (7) 1-38.
10.3390/cancers12071929
Duffy SW, Tabár L, Yen AMF, Dean PB, Smith RA, Jonsson H, Törnberg S, Chen SLS et al.(2020). Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women. Cancer vol. 126, (13) 2971-2979.
10.1002/cncr.32859
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64451
Chang RWJ, Chuang SL, Hsu CY, Yen AMF, Wu WYY, Chen SLS, Fann JCY, Tabar L et al.(2020). Precision science on incidence and progression of early-detected small breast invasive cancers by mammographic features. Cancers vol. 12, (7) 1-14.
10.3390/cancers12071855
Ruparel M, Quaife SL, Dickson JL, Horst C, Tisi S, Hall H, Taylor MN, Ahmed A et al.(2020). Prevalence, symptom burden, and underdiagnosis of chronic obstructive pulmonary disease in a lung cancer screening cohort. Annals of the American Thoracic Society vol. 17, (7) 869-878.
10.1513/AnnalsATS.201911-857OC
French DP, Astley S, Astley S, Brentnall AR, Cuzick J, Dobrashian R, Duffy SW, Gorman LS et al.(2020). What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420). BMC Cancer vol. 20, (1)
10.1186/s12885-020-07054-2
https://qmro.qmul.ac.uk/xmlui/handle/123456789/65329
Saz-Parkinson Z, Duffy SW, Canelo-Aybar C, Gräwingholt A, Quinn C, Follmann M, Schünemann HJ(2020). Breast Cancer Screening and Diagnosis. Ann Intern Med vol. 172, (12) 840-841.
10.7326/L20-0254
Baldeh T, Saz-Parkinson Z, Muti P, Santesso N, Morgano GP, Wiercioch W, Nieuwlaat R, Gräwingholt A et al.(2020). Development and use of health outcome descriptors: A guideline development case study. Health and Quality of Life Outcomes vol. 18, (1)
10.1186/s12955-020-01338-8
https://qmro.qmul.ac.uk/xmlui/handle/123456789/65121
Perry N, Moss S, Dixon S, Milner S, Mokbel K, Lemech C, Arkenau HT, Duffy S et al.(2020). Mammographic breast density and urbanization: Interactions with BMI, environmental, lifestyle, and other patient factors. Diagnostics vol. 10, (6)
10.3390/diagnostics10060418
MacInnes EG, Duffy SW, Simpson JA, Wallis MG, Turnbull AE, Wilkinson LS, Satchithananda K, Rahim R et al.(2020). Radiological audit of interval breast cancers: Estimation of tumour growth rates. Breast vol. 51, 114-119.
10.1016/j.breast.2020.03.006
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64448
Peto J, Carpenter J, Smith GD, Duffy S, Houlston R, Hunter DJ, McPherson K, Pearce N et al.(2020). Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic. R Soc Open Sci vol. 7, (6)
10.1098/rsos.200915
Peto J, Carpenter J, Smith GD, Duffy S, Houlston R, Hunter DJ, Mcpherson K, Pearce N et al.(2020). Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic: Weekly Covid-19 testing. Royal Society Open Science vol. 7, (6)
10.1098/rsos.200915rsos200915
Quaife SL, Ruparel M, Dickson JL, Beeken RJ, McEwen A, Baldwin DR, Bhowmik A, Navani N et al.(2020). Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials. American journal of respiratory and critical care medicine vol. 201, (8) 965-975.
10.1164/rccm.201905-0946OC
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64450
Dibden A, Offman J, Duffy SW, Gabe R(2020). Worldwide review and meta-analysis of cohort studies measuring the effect of mammography screening programmes on incidence-based breast cancer mortality. Cancers vol. 12, (4)
10.3390/cancers12040976
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64751
MacInnes EGE, Duffy SW, Simpson JA, Wallis MG, Turnbull AE, Wilkinson LS, Satchithananda K, Rahim R et al. (2020). Tumour volume doubling times: clinicopathological factors that correlate with increased growth rates. BREAST CANCER RESEARCH AND TREATMENT. vol. 180, 555-555.
Blyuss O, Zaikin A, Cherepanova V, Munblit D, Kiseleva EM, Prytomanova OM, Duffy SW, Crnogorac-Jurcevic T(2020). Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients. British Journal of Cancer vol. 122, (5) 692-696.
10.1038/s41416-019-0694-0
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63621
Bright CJ, Brentnall AR, Wooldrage K, Myles J, Sasieni P, Duffy SW(2020). Errors in determination of net survival: cause-specific and relative survival settings. British Journal of Cancer
10.1038/s41416-020-0739-4
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63283
Duffy SW, Field JK(2020). Mortality reduction with low-dose CT screening for lung cancer. New England Journal of Medicine vol. 382, (6) 572-573.
10.1056/NEJMe1916361
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64500
Evans DG, Edwards M, Duffy SW, Adlard J, Ahmed M, Barwell J, Brady A, Brennan P et al.(2020). Sporadic implementation of UK familial mammographic surveillance guidelines 15 years after original publication. British Journal of Cancer vol. 122, (3) 329-332.
10.1038/s41416-019-0631-2
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64453
Cross AJ, Robbins EC, Pack K, Stenson I, Kirby PL, Patel B, Rutter MD, Veitch AM et al.(2020). Long-term colorectal cancer incidence after adenoma removal and the effects of surveillance on incidence: a multicentre, retrospective, cohort study. Gut
10.1136/gutjnl-2019-320036
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62538
Schünemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, Lebeau A, Nyström L et al.(2020). Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines. Ann Intern Med vol. 172, (1) 46-56.
10.7326/M19-2125
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63861
Tabár L, Chen THH, Yen AMF, Dean PB, Smith RA, Jonsson H, Törnberg S, Chen SLS et al.(2020). Early detection of breast cancer rectifies inequality of breast cancer outcomes. Journal of Medical Screening
10.1177/0969141320921210
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64020
Ghimire B, Maroni R, Vulkan D, Shah Z, Gaynor E, Timoney M, Jones L, Arvanitis R et al.(2020). Erratum to “Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme” (Lung Cancer (2019) 134 (66–71), (S0169500219304702), (10.1016/j.lungcan.2019.05.026)). Lung Cancer vol. 139,
10.1016/j.lungcan.2019.10.007
Duffy SW, Smith RA(2020). The Evaluation of Cancer Screening: Concepts and Outcome Measures. Medical Clinics of North America
10.1016/j.mcna.2020.07.002
Ruparel M, Quaife SL, Dickson JL, Horst C, Burke S, Taylor M, Ahmed A, Shaw P et al.(2019). Evaluation of cardiovascular risk in a lung cancer screening cohort. Thorax vol. 74, (12) 1140-1146.
10.1136/thoraxjnl-2018-212812
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62204
Hall H, Ruparel M, Quaife S, Dickson J, Horst C, Tisi S, Batty J, Woznitza N et al. (2019). P78 The role of computer-assisted radiographer reporting in lung cancer screening programmes. Thorax. vol. 74,
10.1136/thorax-2019-btsabstracts2019.221
Havariyoun G, Vittoria FA, Hagen CK, Basta D, Kallon GK, Endrizzi M, Massimi L, Munro P et al.(2019). A compact system for intraoperative specimen imaging based on edge illumination x-ray phase contrast. Physics in Medicine and Biology vol. 64, (23)
10.1088/1361-6560/ab4912
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62978
Soo E, Edey AJ, Mak SM, Moser J, Mohammadi S, Rodrigues T, Duffy SW, Field JK et al.(2019). Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screening. European Journal of Radiology vol. 120,
10.1016/j.ejrad.2019.108646
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63786
Sun L, Brentnall A, Patel S, Buist D, Bowles E, Evans D, Eccles D, Hopper J et al. (2019). Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis. International Journal of Gynecological Cancer. vol. 29,
10.1136/ijgc-2019-esgo.31
Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, Eccles D, Hopper J et al.(2019). A Cost-effectiveness Analysis of Multigene Testing for All Patients with Breast Cancer. JAMA Oncology
10.1001/jamaoncol.2019.3323
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64584
Marcus M, Duffy S, Devaraj A, Oudkerk M, Baldwin D, Field J (2019). P1.11-32 The UKLS Nodule Risk Model (UKLS-NRM): Utilising Nodule Volumetry. Journal of Thoracic Oncology. vol. 14,
10.1016/j.jtho.2019.08.1105
Sun L, Brentnall A, Patel S, Buist SM D, Bowles JA E, Evans R DG, Eccles D, Hopper J et al.(2019). 66 Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis. Regional plenary
10.1136/ijgc-2019-igcs.66
https://qmro.qmul.ac.uk/xmlui/handle/123456789/65196
Manchanda R, Sun L, Patel S, Wilschut J, de Freitas ALC, Brentnall A, Duffy S, Cui B et al. (2019). 10 Global economic evaluation of population-based BRCA1/BRCA2 mutation testing. International Journal of Gynecological Cancer. vol. 29,
10.1136/ijgc-2019-igcs.10
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63059
Cross AJ, Wooldrage K, Robbins EC, Kralj-Hans I, MacRae E, Piggott C, Stenson I, Prendergast A et al.(2019). Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: A diagnostic accuracy and cost-effectiveness study. Gut vol. 68, (9) 1642-1652.
10.1136/gutjnl-2018-317297
https://qmro.qmul.ac.uk/xmlui/handle/123456789/55753
Schünemann HJ, Lerda D, Dimitrova N, Alonso-Coello P, Gräwingholt A, Quinn C, Follmann M, Mansel R et al.(2019). Methods for development of the european commission initiative on breast cancer guidelines. Annals of Internal Medicine vol. 171, (4) 273-280.
10.7326/M18-3445
https://qmro.qmul.ac.uk/xmlui/handle/123456789/60051
Ghimire B, Maroni R, Vulkan D, Shah Z, Gaynor E, Timoney M, Jones L, Arvanitis R et al.(2019). Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme. Lung Cancer vol. 134, 66-71.
10.1016/j.lungcan.2019.05.026
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58971
Rebolj M, Blyuss O, Chia KS, Duffy SW(2019). Long-term excess risk of breast cancer after a single breast density measurement. European Journal of Cancer vol. 117, 41-47.
10.1016/j.ejca.2019.05.009
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58600
Duffy SW, Smith RA, Tabár L, Dean PB, Chen THH(2019). Reply to The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer vol. 125, (12) 2130-2131.
10.1002/cncr.32007
https://qmro.qmul.ac.uk/xmlui/handle/123456789/55371
Blyuss O, Duffy S, Crnogorac-Jurcevic T (2019). Development of a biomarker panel risk score, PancRISK, for early detection of pancreatic cancer.
Ruparel M, Quaife SL, Ghimire B, Dickson JL, Bhowmik A, Navani N, Baldwin DR, Duffy S et al.(2019). Impact of a Lung Cancer Screening Information Film on Informed Decision-making: A Randomized Trial. Ann Am Thorac Soc vol. 16, (6) 744-751.
10.1513/AnnalsATS.201811-841OC
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58502
Aarts AMWM, Duffy SW, Geurts SME, Vulkan DP, Houssami N, Zappa M, Nagtegaal ID, Verbeek ALM et al.(2019). Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer. Breast vol. 45, 70-74.
10.1016/j.breast.2019.03.003
https://qmro.qmul.ac.uk/xmlui/handle/123456789/64452
Ruparel M, Quaife SL, Dickson JL, Horst C, Burke SJ, Taylor M, Ahmed A, Shaw P et al. (2019). Is Lung Cancer Screening an Opportunity to Reduce Cardiovascular Mortality?. a5896-a5896.
10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5896
Ruparel M, Quaife SL, Dickson JL, Tisi S, Hall H, Horst C, Taylor M, Ahmed A et al. (2019). Prevalence, Symptom Burden and Under-Diagnosis of COPD in a Lung Cancer Screening Cohort. a4469-a4469.
10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4469
Wu WY-Y, Tabar L, Tot T, Fann C-Y, Yen AM-F, Chen SL-S, Chiu SY-H, Ku MM-S et al.(2019). Imaging Biomarkers as Predictors for Breast Cancer Death. J Oncol vol. 2019, 2087983-2087983.
10.1155/2019/2087983
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58501
Singh D, Miettinen J, Duffy S, Malila N, Pitkäniemi J, Anttila A(2019). Correction: Association of symptoms and interval breast cancers in the mammography-screening programme: population-based matched cohort study (British Journal of Cancer, (2018), 119, 11, (1428-1435), 10.1038/s41416-018-0308-2). British Journal of Cancer vol. 120, (7) 773-774.
10.1038/s41416-019-0417-6
Kerrison RS, von Wagner C, Green T, Gibbins M, Macleod U, Hughes M, Rees CJ, Duffy S et al.(2019). Rapid review of factors associated with flexible sigmoidoscopy screening use. Prev Med vol. 120, 8-18.
10.1016/j.ypmed.2018.12.018
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54758
Quaife S, Ruparel M, Dickson J, Beeken RJ, McEwen A, Baldwin D, Bhowmik A, Navani N et al. (2019). THE LUNG SCREEN UPTAKE TRIAL (LSUT): TESTING TARGETED INVITATION MATERIALS TO OPTIMISE INFORMED UPTAKE AMONG HIGH-RISK GROUPS. ANNALS OF BEHAVIORAL MEDICINE. vol. 53, S21-S21.
Tabár L, Dean PB, Chen THH, Yen AMF, Chen SLS, Fann JCY, Chiu SYH, Ku MMS et al.(2019). The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer vol. 125, (4) 515-523.
10.1002/cncr.31840
https://qmro.qmul.ac.uk/xmlui/handle/123456789/55370
BROWN TW, Greenhough B, DYCK I, raven-ellison M, ORNSTEIN M, DUFFY S(2019). “They say it’s more aggressive in black women”: Biosociality, breast cancer and becoming a population ‘at risk’. Transactions of the Institute of British Geographers
10.1111/tran.12290
https://qmro.qmul.ac.uk/xmlui/handle/123456789/55730
Evans DG, Thomas S, Caunt J, Burch A, Brentnall AR, Roberts L, Howell A, Wilson M et al.(2019). Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35-39 at Increased Familial Risk of Breast Cancer. EClinicalMedicine vol. 7, 39-46.
10.1016/j.eclinm.2019.01.005
https://qmro.qmul.ac.uk/xmlui/handle/123456789/57096
Weber MF, Marshall HM, Rankin N, Duffy S, Fong KM, Dunlop K, Humphreys L, Smit AK et al.(2019). Cancer screening in Australia: Future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers. Public Health Research and Practice vol. 29, (2)
10.17061/phrp2921910
https://qmro.qmul.ac.uk/xmlui/handle/123456789/66481
Rebolj M, Parmar D, Maroni R, Blyuss O, Duffy SW(2019). Concurrent participation in screening for cervical, breast, and bowel cancer in England. Journal of Medical Screening
10.1177/0969141319871977
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62218
Atkin W, Cross AJ, Kralj-Hans I, Macrae E, Piggott C, Pearson S, Wooldrage K, Brown J et al.(2019). Faecal immunochemical tests versus colonoscopy for post-poly pectomy surveillance: An accuracy, acceptability and economic study. Health Technology Assessment vol. 23, (1) I-84.
10.3310/hta23010
https://qmro.qmul.ac.uk/xmlui/handle/123456789/55186
Woznitza N, Devaraj A, Janes S, Duffy S, Rowe S, Bhowmik A, Maughn S, Piper K et al.(2019). Impact of radiographer immediate reporting of chest x-rays from general practice on the lung cancer pathway (radioX). Lung Cancer vol. 127,
10.1016/s0169-5002(19)30073-x
Massimi L, Hagen CK, Endrizzi M, Munro PRT, Havariyoun G, Hawker PMS, Smit B, Astolfo A et al. (2019). Laboratory-based x-ray phase contrast CT technology for clinical intra-operative specimen imaging. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. vol. 10948,
10.1117/12.2511770
Horst C, Ruparel M, Dickson J, Quaife S, Hall H, Tisi S, Taylor M, Ahmed A et al.(2019). Optimising nodule management with data from the Lung Screen Uptake Trial. Lung Cancer vol. 127,
10.1016/s0169-5002(19)30099-6
Marcus MW, Duffy SW, Devaraj A, Green BA, Oudkerk M, Baldwin D, Field J(2019). Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: The UKLS trial. Thorax
10.1136/thoraxjnl-2018-212263
https://qmro.qmul.ac.uk/xmlui/handle/123456789/57826
Ruparel M, Dickson J, Quaife S, Sophie T, Hall H, Horst C, Taylor M, Ahmed A et al.(2019). Results from a prevalence round of LDCT screening for lung cancer in the Lung Screen Uptake Trial. Lung Cancer vol. 127, s22-s23.
10.1016/s0169-5002(19)30100-x
Fidoe D, Hill S, Gaynor E, Field J, Duffy S, Ledson M, Grundy S (2018). P185 Liverpool healthy lung project: detection of undiagnosed airways disease and significant other findings in a risk stratified lung health check. a201.1-a2a201.
10.1136/thorax-2018-212555.342
Singh D, Miettinen J, Duffy S, Malila N, Pitkäniemi J, Anttila A(2018). Association of symptoms and interval breast cancers in the mammography-screening programme: population-based matched cohort study. British Journal of Cancer vol. 119, (11) 1428-1435.
10.1038/s41416-018-0308-2
https://qmro.qmul.ac.uk/xmlui/handle/123456789/56046
Rebolj M, Brentnall A, Duffy SW(2018). Reply to ‘Comment on ‘Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis”. British Journal of Cancer vol. 119, (11)
10.1038/s41416-018-0247-y
https://qmro.qmul.ac.uk/xmlui/handle/123456789/56395
Birge M, Duffy S, Miler JA, Hajek P(2018). What Proportion of People Who Try One Cigarette Become Daily Smokers? A Meta-Analysis of Representative Surveys. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco vol. 20, (12) 1427-1433.
10.1093/ntr/ntx243
https://qmro.qmul.ac.uk/xmlui/handle/123456789/35923
Ruparel M, Quaife S, Ghimire B, Dickson J, Horst C, Tisi S, Bhowmik A, Navani N et al. (2018). Impact of an Information-Film to Promote Informed Decision-Making in Individuals Taking Part in a Lung Cancer Screening Demonstration Pilot. JOURNAL OF THORACIC ONCOLOGY. vol. 13, S790-S790.
Ruparel M, Quaife S, Ghimire B, Dickson J, Horst C, Tisi S, Bhowmik A, Navani N et al.(2018). P2.11-29 Impact of an Information-Film to Promote Informed Decision-Making in Individuals Taking Part in a Lung Cancer Screening Demonstration Pilot. Journal of Thoracic Oncology vol. 13, (10)
10.1016/j.jtho.2018.08.1376
Ledson M, Gaynor E, Grundy S, Hill S, Fidoe D, Mason S, Duffy S, Field J (2018). P3.11-13 Liverpool Identifies the Hard to Reach Population at Risk of Developing Lung Cancer. Journal of Thoracic Oncology. vol. 13, s963-s964.
10.1016/j.jtho.2018.08.1809
Broeders MJM, Allgood P, Duffy SW, Hofvind S, Nagtegaal ID, Paci E, Moss SM, Bucchi L(2018). The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: A literature review. BMC Cancer vol. 18, (1)
10.1186/s12885-018-4666-1
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54760
Gnatiuc L, Herrington WG, Halsey J, Tuomilehto J, Fang X, Kim HC, De Bacquer D, Dobson AJ et al.(2018). Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies. The Lancet Diabetes and Endocrinology vol. 6, (7) 538-546.
10.1016/S2213-8587(18)30079-2
https://qmro.qmul.ac.uk/xmlui/handle/123456789/55343
Field JK, Duffy SW(2018). Lung cancer CT screening: Are we ready to consider screening biennially in a subgroup of low-risk individuals?. Thorax
10.1136/thoraxjnl-2018-211814
https://qmro.qmul.ac.uk/xmlui/handle/123456789/43425
Rebolj M, Assi V, Brentnall A, Parmar D, Duffy SW(2018). Addition of ultrasound to mammography in the case of dense breast tissue: Systematic review and meta-analysis. British Journal of Cancer vol. 118, (12) 1559-1570.
10.1038/s41416-018-0080-3
https://qmro.qmul.ac.uk/xmlui/handle/123456789/45083
Robbins E, Wooldrage K, MacRae E, Stenson I, Patel B, Pack K, Piggott C, Pearson S et al. (2018). OTU-029 Faecal immunochemical tests (FIT) for surveillance after screening and polypectomy: an accuracy and efficiency study. a222.2-a2a222.
10.1136/gutjnl-2018-bsgabstracts.443
Maringe C, Pashayan N, Rubio FJ, Ploubidis G, Duffy SW, Rachet B, Raine R(2018). Trends in lung cancer emergency presentation in England, 2006-2013: Is there a pattern by general practice?. BMC Cancer vol. 18, (1)
10.1186/s12885-018-4476-5
https://qmro.qmul.ac.uk/xmlui/handle/123456789/40463
von Wagner C, Hirst Y, Tookey S, Kerrison RS, Marshall S, Prentice A, Vulkan D, Macleod U et al.(2018). Use of a GP-endorsed 12 months' reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population. BMJ Open vol. 8, (5) e022263-e022263.
10.1136/bmjopen-2018-022263
https://qmro.qmul.ac.uk/xmlui/handle/123456789/39448
Burnside ES, Vulkan D, Blanks RG, Duffy SW(2018). Association between Screening Mammography Recall Rate and Interval Cancers in the UK Breast Cancer Service Screening Program: A Cohort Study. Radiology vol. 288, (1) 47-54.
10.1148/radiol.2018171539
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58642
Singh D, Miettinen J, Duffy S, Malila N, Pitkaniemi J, Anttila A (2018). Breast symptoms and risk of interval breast cancers in mammography-screening programme. EUROPEAN JOURNAL OF CANCER. vol. 92, S11-S11.
Field JK, Duffy SW, Baldwin DR(2018). Patient selection for future lung cancer computed tomography screening programmes: Lessons learnt post National Lung Cancer Screening Trial. Translational Lung Cancer Research vol. 7, S114-S116.
10.21037/tlcr.2018.03.12
https://qmro.qmul.ac.uk/xmlui/handle/123456789/59010
Field JK, Heuvelmans MA, Devaraj A, Heussel CP, Baldwin DR, Vliegenthart R, Duffy SW, Oudkerk M(2018). Low-dose CT for lung cancer screening – Authors' reply. The Lancet Oncology vol. 19, (3) e135-e136.
10.1016/S1470-2045(18)30122-0
https://qmro.qmul.ac.uk/xmlui/handle/123456789/56456
Tabar L, Chen THH, Yen AMF, Chen SLS, Fann JCY, Chiu SYH, Ku MMS, Wu WYY et al.(2018). Effect of mammography screening on mortality by histological grade. Cancer Epidemiology Biomarkers and Prevention vol. 27, (2) 154-157.
10.1158/1055-9965.EPI-17-0487
https://qmro.qmul.ac.uk/xmlui/handle/123456789/56655
Ruparel M, Quaife S, Dickson J, Whipp C, Salgado J, Dutta N, Ovayolu D, Patel K et al.(2018). 126 Impact of an information-film to promote informed decision-making in individuals taking part in a lung cancer screening demonstration pilot. Lung Cancer vol. 115,
10.1016/s0169-5002(18)30152-1
Ruparel M, Quaife S, Dickson J, Whipp C, Salgado J, Dutta N, Ovayolu D, Patel K et al. (2018). Impact of an information-film to promote informed decision-making in individuals taking part in a lung cancer screening demonstration pilot. LUNG CANCER. vol. 115, S53-S53.
Duffy SW(2018). Risk stratification in breast screening: A word of caution. Journal of Medical Screening
10.1177/0969141318813387
https://qmro.qmul.ac.uk/xmlui/handle/123456789/53223
Aarts AMWM, Duffy SW, Geurts SME, Vulkan DP, Otten JDM, Hsu CY, Chen THH, Verbeek ALM et al.(2018). Test sensitivity of mammography and mean sojourn time over 40 years of breast cancer screening in Nijmegen (The Netherlands). Journal of Medical Screening
10.1177/0969141318814869
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54759
Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel CP, Bastarrika G, Sverzellati N et al.(2017). European position statement on lung cancer screening. The Lancet Oncology vol. 18, (12) e754-e766.
10.1016/S1470-2045(17)30861-6
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58972
Brown T, Dyck I, Greenhough B, Raven-Ellison M, Dembinsky M, Ornstein M, Duffy SW(2017). Fear, family and the placing of emotion: Black women's responses to a breast cancer awareness intervention. Social Science and Medicine vol. 195, 90-96.
10.1016/j.socscimed.2017.10.037
https://qmro.qmul.ac.uk/xmlui/handle/123456789/39114
Ruparel M, Quaife S, Dickson J, Bhowmik A, Taylor M, Ahmed A, Shaw P, Burke S et al. (2017). S11 Identification and attendance of a high-risk cohort in a lung cancer screening demonstration pilot. Thorax. vol. 72,
10.1136/thoraxjnl-2017-210983.17
Ruparel M, Dickson J, Quaife S, Bhowmik A, Taylor M, Ahmed A, Shaw P, Burke S et al. (2017). S14 Lung cancer risk profiles and eligibility of attendees in a lung cancer screening demonstration pilot. Thorax. vol. 72,
10.1136/thoraxjnl-2017-210983.20
Duffy SW, Morrish OWE, Allgood PC, Black R, Gillan MGC, Willsher P, Cooke J, Duncan KA et al.(2017). Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer. Eur J Cancer vol. 88, 48-56.
10.1016/j.ejca.2017.10.022
https://qmro.qmul.ac.uk/xmlui/handle/123456789/54844
Price S, Duffy S, Gori M (2017). Developing a pedagogical framework for designing a multisensory serious gaming environment. MIE 2017 - Proceedings of the 1st ACM SIGCHI International Workshop on Multimodal Interaction for Education, Co-located with ICMI 2017. vol. 2017-November, 1-9.
10.1145/3139513.3139517
Woznitza N, Devaraj A, Janes SM, Duffy SW, Bhowmik A, Rowe S, Piper K, Maughn S et al.(2017). Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial. Trials vol. 18, (1) 521-521.
10.1186/s13063-017-2268-x
https://qmro.qmul.ac.uk/xmlui/handle/123456789/33664
Chen THH, Duffy SW(2017). To the editor. Annals of Internal Medicine vol. 167, (7) 523-524.
10.7326/L17-0267
Maxwell AJ, Michell M, Lim YY, Astley SM, Wilson M, Hurley E, Evans DG, Howell A et al.(2017). A randomised trial of screening with digital breast tomosynthesis plus conventional digital 2D mammography versus 2D mammography alone in younger higher risk women. European Journal of Radiology vol. 94, 133-139.
10.1016/j.ejrad.2017.06.018
Smith SG, Wardle J, Atkin W, Raine R, McGregor LM, Vart G, Morris S, Duffy SW et al.(2017). Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial. BMC Cancer vol. 17, (1) 543-543.
10.1186/s12885-017-3512-1
https://qmro.qmul.ac.uk/xmlui/handle/123456789/33984
Atkin W, Wooldrage K, Sasieni P, Duffy SW, Cross AJ (2017). Colorectal adenomas, surveillance, and cancer. vol. 18, is. 8, pp. E428-E428.
10.1016/S1470-2045(17)30532-6
Atkin W, Wooldrage K, Sasieni P, Duffy SW, Cross AJ(2017). Colorectal adenomas, surveillance, and cancer – Authors' reply. The Lancet Oncology vol. 18, (8)
10.1016/S1470-2045(17)30532-6
https://qmro.qmul.ac.uk/xmlui/handle/123456789/25769
Brain K, Carter B, Lifford KJ, Burke O, Devaraj A, Baldwin DR, Duffy S, Field JK(2017). Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial. Thorax vol. 72, (10) 912-918.
10.1136/thoraxjnl-2016-209690
https://qmro.qmul.ac.uk/xmlui/handle/123456789/56654
HEALEY PGT, Duffy(2017). A New Medium for Remote Music Tuition. Journal of Music, Technology and Education vol. 10, (1)
10.1386/jmte.10.1.5_1
https://qmro.qmul.ac.uk/xmlui/handle/123456789/24849
Nair A, Screaton NJ, Holemans JA, Jones D, Clements L, Barton B, Gartland N, Duffy SW et al.(2017). The impact of trained radiographers as concurrent readers on performance and reading time of experienced radiologists in the UK Lung Cancer Screening (UKLS) trial. Eur Radiol vol. 28, (1) 226-234.
10.1007/s00330-017-4903-z
https://qmro.qmul.ac.uk/xmlui/handle/123456789/35603
Beruchashwili T, Gvamichava R, Duffy SW(2017). Screening organization and recall rate in a regional breast screening programme. J Med Screen vol. 25, (1) 55-56.
10.1177/0969141317704680
https://qmro.qmul.ac.uk/xmlui/handle/123456789/59046
Sheringham J, Sequeira R, Myles J, Hamilton W, McDonnell J, Offman J, Duffy S, Raine R(2017). Variations in GPs' decisions to investigate suspected lung cancer: A factorial experiment using multimedia vignettes. BMJ Quality and Safety vol. 26, (6) 449-459.
10.1136/bmjqs-2016-005679
https://qmro.qmul.ac.uk/xmlui/handle/123456789/59406
Benton SC, Butler P, Allen K, Chesters M, Rickard S, Stanley S, Roope R, Vulkan D et al.(2017). GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project. Br J Cancer vol. 116, (12) 1551-1557.
10.1038/bjc.2017.129
https://qmro.qmul.ac.uk/xmlui/handle/123456789/33423
Allgood, MARONI R, Hudson S, Offman, Turnbull AE, Peacock L, Steel J, Kirby G et al.(2017). The effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial. Lancet Oncology
10.1016/S1470-2045(17)30340-6
https://qmro.qmul.ac.uk/xmlui/handle/123456789/22345
Tucker L, Gilbert FJ, Astley SM, Dibden A, Seth A, Morel J, Bundred S, Litherland J et al.(2017). Does reader performance with digital breast tomosynthesis vary according to experience with two-dimensional mammography?. Radiology vol. 283, (2) 371-380.
10.1148/radiol.2017151936
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58499
Atkin W, Wooldrage K, Brenner A, Martin J, Shah U, Perera S, Lucas F, Brown JP et al.(2017). Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study. Lancet Oncol vol. 18, (6) 823-834.
10.1016/S1470-2045(17)30187-0
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34784
Duffy SW, Etzioni R, Sasieni P(2017). Both a stage shift and changes in stage-specific survival have contributed to reductions in breast cancer mortality. Evidence-Based Medicine vol. 22, (2)
10.1136/ebmed-2016-110632
https://qmro.qmul.ac.uk/xmlui/handle/123456789/25766
Atkin W, Wooldrage K, Parkin DM, Kralj-Hans I, MacRae E, Shah U, Duffy S, Cross AJ(2017). Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial. The Lancet vol. 389, (10076) 1299-1311.
10.1016/S0140-6736(17)30396-3
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58503
Raine R, Atkin W, von Wagner C, Duffy S, Kralj-Hans I, Hackshaw A, Counsell N, Moss S et al.(2017). Testing innovative strategies to reduce the social gradient in the uptake of bowel cancer screening: a programme of four qualitatively enhanced randomised controlled trials. Programme Grants for Applied Research vol. 5, (8) 1-302.
10.3310/pgfar05080
https://qmro.qmul.ac.uk/xmlui/handle/123456789/66876
Brentnall AR, Duffy SW, Cuzick J (2017). To the editor. vol. 376, is. 1,
10.1056/NEJMc1614282
Baldwin DR, Duffy SW, Devaraj A, Field JK(2017). Optimum low dose CT screening interval for lung cancer: The answer from NELSON?. Thorax vol. 72, (1) 6-7.
10.1136/thoraxjnl-2016-209011
Atkin W, Brenner A, Martin J, Wooldrage K, Shah U, Lucas F, Greliak P, Pack K et al.(2017). The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediategrade colorectal adenomas: A retrospective cohort analysis, and psychological and economic evaluations. Health Technology Assessment vol. 21, (25)
10.3310/hta21250
https://qmro.qmul.ac.uk/xmlui/handle/123456789/55751
Yen AM-F, Wu WY-Y, Tabar L, Duffy SW, Smith RA, Chen H-H(2016). Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancer. J Epidemiol vol. 27, (3) 98-106.
10.1016/j.je.2016.10.003
https://qmro.qmul.ac.uk/xmlui/handle/123456789/33963
Raine R, Moss SM, von Wagner C, Atkin W, Hans IK, Howe R, Solmi F, Morris S et al.(2016). A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening. Br J Cancer vol. 115, (12) 1479-1486.
10.1038/bjc.2016.365
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34505
Duffy SW, Myles JP, MARONI R, Mohammad A(2016). Rapid review of evaluation of interventions to improve participation in cancer screening services. Journal of Medical Screening
10.1177/0969141316664757
https://qmro.qmul.ac.uk/xmlui/handle/123456789/16187
Field JK, Duffy SW, Devaraj A, Baldwin DR(2016). Implementation planning for lung cancer screening: five major challenges. The Lancet Respiratory Medicine vol. 4, (9) 685-687.
10.1016/S2213-2600(16)30233-8
Niksic M, Rachet B, Duffy SW, Quaresma M, Møller H, Forbes LJ(2016). Is cancer survival associated with cancer symptom awareness and barriers to seeking medical help in England? An ecological study. Br J Cancer vol. 115, (7) 876-886.
10.1038/bjc.2016.246
https://qmro.qmul.ac.uk/xmlui/handle/123456789/35203
Nair A, Gartland N, Barton B, Jones D, Clements L, Screaton NJ, Holemans JA, Duffy SW et al.(2016). Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial. Br J Radiol vol. 89, (1066) 20160301-20160301.
10.1259/bjr.20160301
Brain K, Lifford KJ, Carter B, Burke O, McRonald F, Devaraj A, Hansell DM, Baldwin D et al.(2016). Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial. Thorax vol. 71, (11) 996-1005.
10.1136/thoraxjnl-2016-208283
https://qmro.qmul.ac.uk/xmlui/handle/123456789/35223
Greenhough B, Dembinsky M, Dyck I, Brown T, Robson J, Homer K, Sajani C, Carter L et al.(2016). Evaluating a DVD promoting breast cancer awareness among black women aged 25-50 years in East London. Journal of Epidemiology and Community Health vol. 70, (7) 678-682.
10.1136/jech-2015-206540
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12431
Marcus MW, Raji OY, Duffy SW, Young RP, Hopkins RJ, Field JK(2016). Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model. International Journal of Oncology vol. 49, (1) 361-370.
10.3892/ijo.2016.3499
Sasieni PD, Duffy SW, Cuzick J (2016). Ovarian cancer screening: UKCTOCS trial. vol. 387, is. 10038,
10.1016/S0140-6736(16)30847-9
Bjurstam NG, Björneld LM, Duffy SW(2016). Updated results of the Gothenburg Trial of Mammographic Screening. Cancer vol. 122, (12) 1832-1835.
10.1002/cncr.29975
Butler P, Duffy S, Reed K, Chesters M, Stanley S, Rickard S, Roope R, Benton S (2016). GP PARTICIPATION IN INCREASING UPTAKE IN BOWEL CANCER SCREENING: THE PEARL PROJECT. GUT. Conference: BSG 2016 vol. 65, A194-A195.
10.1136/gutjnl-2016-312388.359
Burnside ES, Sickles EA, Duffy SW(2016). A pragmatic approach to determine components of optimal screening mammography practice. JAMA - Journal of the American Medical Association vol. 315, (18) 1951-1953.
10.1001/jama.2016.4530
Massat NJ, Dibden A, Parmar D, Cuzick J, Sasieni PD, Duffy SW(2016). Impact of screening on breast cancer mortality-response. Cancer Epidemiology Biomarkers and Prevention vol. 25, (5)
10.1158/1055-9965.EPI-16-0170
Field JK, Duffy SW, Baldwin DR, Brain KE, Devaraj A, Eisen T, Green BA, Holemans JA et al.(2016). The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technology Assessment vol. 20, (40) 1-146.
10.3310/hta20400
Tabar L, Chen TH-H, Hsu C-Y, Wu WY-Y, Yen AM-F, Chen SL-S, Chiu SY-H, Fann JC-Y et al.(2016). Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review. J Med Screen vol. 24, (1) 27-33.
10.1177/0969141316631375
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34431
Quaife SL, Ruparel M, Beeken RJ, McEwen A, Isitt J, Nolan G, Sennett K, Baldwin DR et al.(2016). The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients. BMC Cancer vol. 16, 281-281.
10.1186/s12885-016-2316-z
https://qmro.qmul.ac.uk/xmlui/handle/123456789/34470
Field JK, Duffy SW(2016). Lung cancer CT screening: is annual screening necessary?. The Lancet Oncology vol. 17, (5) 543-544.
10.1016/S1470-2045(16)00079-6
Duffy SW(2016). DCIS and invasive interval breast cancer - Author's reply. The Lancet Oncology vol. 17, (3) e88-e89.
10.1016/S1470-2045(16)00104-2
Massat NJ, Sasieni PD, Tataru D, Parmar D, Cuzick J, Duffy SW(2016). Explaining the better prognosis of screening-exposed breast cancers: Influence of tumor characteristics and treatment. Cancer Epidemiology Biomarkers and Prevention vol. 25, (3) 479-487.
10.1158/1055-9965.EPI-15-0804
https://qmro.qmul.ac.uk/xmlui/handle/123456789/11307
Massat NJ, Dibden A, Parmar D, Cuzick J, Sasieni PD, Duffy SW(2016). Impact of screening on breast cancer mortality: The UK program 20 years on. Cancer Epidemiology Biomarkers and Prevention vol. 25, (3) 455-462.
10.1158/1055-9965.EPI-15-0803
https://qmro.qmul.ac.uk/xmlui/handle/123456789/10511
Wardle J, Von Wagner C, Kralj-Hans I, Halloran SP, Smith SG, McGregor LM, Vart G, Howe R et al.(2016). Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): Four cluster-randomised controlled trials. The Lancet vol. 387, (10020) 751-759.
10.1016/S0140-6736(15)01154-X
https://qmro.qmul.ac.uk/xmlui/handle/123456789/11072
Raine R, Duffy SW, Wardle J, Solmi F, Morris S, Howe R, Kralj-Hans I, Snowball J et al.(2016). Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening. British Journal of Cancer vol. 114, (3) 321-326.
10.1038/bjc.2015.413
https://qmro.qmul.ac.uk/xmlui/handle/123456789/11075
Duffy SW, Dibden A, Michalopoulas D(2016). Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study (vol 17, pg 109, 2016). LANCET ONCOLOGY vol. 17, (2) E46-E46.
Field JK, Duffy SW, Baldwin DR, Whynes DK, Devaraj A, Brain KE, Eisen T, Gosney J et al.(2016). UK Lung Cancer RCT Pilot Screening Trial: Baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax vol. 71, (2) 161-170.
10.1136/thoraxjnl-2015-207140
Allgood PC, Maxwell AJ, Hudson S, Offman J, Hutchison G, Beattie C, Tuano-Donnelly R, Threlfall A et al.(2016). A randomised trial of the effect of postal reminders on attendance for breast screening. British Journal of Cancer vol. 114, (2) 171-176.
10.1038/bjc.2015.451
https://qmro.qmul.ac.uk/xmlui/handle/123456789/25590
Field JK, Devaraj A, Duffy SW, Baldwin DR(2016). CT screening for lung cancer: Is the evidence strong enough?. Lung Cancer vol. 91, 29-35.
10.1016/j.lungcan.2015.11.003
Hudson S, Brazil D, Teh W, Duffy SW, Myles JP(2016). Effectiveness of timed and non-timed second appointments in improving uptake in breast cancer screening. Journal of Medical Screening vol. 23, (3) 160-163.
10.1177/0969141315624937
Michalopoulos D, Duffy SW(2016). Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian breast screening programme. Journal of Medical Screening vol. 23, (4) 192-202.
10.1177/0969141315623980
McGregor LM, Von Wagner C, Atkin W, Kralj-Hans I, Halloran SP, Handley G, Logan RF, Rainbow S et al.(2016). Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised Trial. Gastroenterology Research and Practice vol. 2016,
10.1155/2016/3670150
https://qmro.qmul.ac.uk/xmlui/handle/123456789/13133
Sasieni PD, Smith RA, Duffy SW(2016). Response to hersch et al. Journal of Medical Screening vol. 23, (1)
10.1177/0969141315613367
Duffy SW, Dibden A, Michalopoulos D, Offman J, Parmar D, Jenkins J, Collins B, Robson T et al.(2016). Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: A retrospective population-based study. The Lancet Oncology vol. 17, (1) 109-114.
10.1016/S1470-2045(15)00446-5
Douglas E, Waller J, Duffy SW, Wardle J(2016). Socioeconomic inequalities in breast and cervical screening coverage in England: Are we closing the gap?. Journal of Medical Screening vol. 23, (2) 98-103.
10.1177/0969141315600192
Duffy SW(2016). The effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy de Gelder R, Heijnsdijk EAM, Fracheboud J, et al (Erasmus Med Ctr, Rotterdam, the Netherlands) Int J Cancer 137:165-172, 2015. Breast Diseases vol. 27, (2) 126-128.
10.1016/j.breastdis.2016.04.003
Gilbert FJ, Tucker L, Gillan MGC, Willsher P, Cooke J, Duncan KA, Michell MJ, Dobson HM et al.(2015). Accuracy of digital breast tomosynthesis for depicting breast cancer subgroups in a UK retrospective reading study (tommy trial)<sup>1</sup>. Radiology vol. 277, (3) 697-706.
10.1148/radiol.2015142566
Seigneurin A, Labarère J, Duffy SW, Colonna M(2015). Overdiagnosis associated with breast cancer screening: A simulation study to compare lead-time adjustment methods. Cancer Epidemiology vol. 39, (6) 1128-1135.
10.1016/j.canep.2015.08.013
Tabar L, Day N, Smith R, Chen THH, Yen AMF, Duffy S(2015). Systematic review of the breast cancer screening trials is error-ridden. Journal of the Royal Society of Medicine vol. 108, (11) 430-431.
10.1177/0141076815620070
Pashayan N, Pharoah PDP, Schleutker J, Talala K, Tammela TLJ, Määttänen L, Harrington P, Tyrer J et al.(2015). Reducing overdiagnosis by polygenic risk-stratified screening: Findings from the Finnish section of the ERSPC. British Journal of Cancer vol. 113, (7) 1086-1093.
10.1038/bjc.2015.289
Moss SM, Wale C, Smith R, Evans A, Cuckle H, Duffy SW(2015). Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: A randomised controlled trial. The Lancet Oncology vol. 16, (9) 1123-1132.
10.1016/S1470-2045(15)00128-X
Field JK, Devaraj A, Baldwin DR, Duffy S (2015). UKLS Impact of Utilization of Risk Assessment in Trial Selection. JOURNAL OF THORACIC ONCOLOGY. vol. 10, S114-S115.
Hyde R, Davies M, Ledson M, Holemans JA, Page RD, Gosney J, Baldwin DR, Devaraj A et al. (2015). Abstract 4602: Exome sequencing of UKLS lung cancer CT screened early stage cancers. 4602-4602.
10.1158/1538-7445.am2015-4602
Pashayan N, Pharoah PDP, Schleutker J, Talala K, Tammela TL, Määttänen L, Harrington P, Tyrer J et al. (2015). Abstract 4681: Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish arm of the European randomised study of screening for prostate cancer (ERSPC). 4681-4681.
10.1158/1538-7445.am2015-4681
Radon TP, Massat NJ, Jones R, Alrawashdeh W, Dumartin L, Ennis D, Duffy SW, Kocher HM et al.(2015). Identification of a three-biomarker panel in urine for early detection of pancreatic adenocarcinoma. Clinical Cancer Research vol. 21, (15) 3512-3521.
10.1158/1078-0432.CCR-14-2467
Morrish OWE, Duffy SW, Gilbert FJ(2015). Response. Radiology vol. 276, (2) 618-619.
10.1148/radiol.2015150302
Morrish OWE, Duffy SW, Gilbert FJ(2015). Response. Radiology vol. 276, (2) 618-619.
Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K, Armstrong B et al.(2015). Breast-cancer screening-viewpoint of the IARC working group. New England Journal of Medicine vol. 372, (24) 2353-2358.
10.1056/NEJMsr1504363
Duffy SW, Smith RA(2015). A note on the design of cancer screening trials. Journal of Medical Screening vol. 22, (2) 65-68.
10.1177/0969141315577847
Brenner A, Martin J, Wooldrage K, Kralj-Hans I, Pack K, Greliak P, Shah U, Dadswell E et al. (2015). PWE-344 Retrospective cohort study to examine the frequency of follow-up for patients with intermediate grade colorectal adenomas (ia study). Gut. vol. 64,
10.1136/gutjnl-2015-309861.790
Brem RF, Tabár L, Duffy SW, Inciardi MF, Guingrich JA, Hashimoto BE, Lander MR, Lapidus RL et al.(2015). Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight Study. Radiology vol. 274, (3) 663-673.
10.1148/radiol.14132832
Zakharova N, Belaya J, Duffy SW, Pyankin S, Pestryakova A(2015). P117 The evaluation of the breast cancer screening programme in Western Siberia. The Breast vol. 24,
10.1016/s0960-9776(15)70159-1
Brentnall AR, Cuzick J, Field J, Duffy SW(2015). A concordance index for matched case-control studies with applications in cancer risk. Stat Med vol. 34, (3) 396-405.
10.1002/sim.6335
https://qmro.qmul.ac.uk/xmlui/handle/123456789/12301
Assi V, Massat NJ, Thomas S, Mackay J, Warwick J, Kataoka M, Warsi I, Brentnall A et al.(2015). A case-control study to assess the impact of mammographic density on breast cancer risk in women aged 40-49 at intermediate familial risk. International Journal of Cancer vol. 136, (10) 2378-2387.
10.1002/ijc.29275
https://qmro.qmul.ac.uk/xmlui/handle/123456789/6662
Beckmann KR, Lynch JW, Hiller JE, Farshid G, Houssami N, Duffy SW, Roder DM(2015). A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening. International Journal of Cancer vol. 136, (6) 1411-1421.
10.1002/ijc.29124
Ali N, Lifford KJ, Carter B, McRonald F, Yadegarfar G, Baldwin DR, Weller D, Hansell DM et al.(2015). Barriers to uptake among high-risk individuals declining participation in lung cancer screening: A mixed methods analysis of the UK lung cancer screening (UKLS) trial. BMJ Open vol. 5, (7)
10.1136/bmjopen-2015-008254
Van Der Waal D, Broeders MJM, Verbeek ALM, Duffy SW, Moss SM(2015). Case-control Studies on the Effectiveness of Breast Cancer Screening: Insights from the UK Age Trial. Epidemiology vol. 26, (4) 590-596.
10.1097/EDE.0000000000000285
Moss SM, Wale C, Smith R, Evans A, Cuckle H, Duffy SW(2015). Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: A randomised controlled trial. The Lancet Oncology
10.1016/S1470-2045(15)00128-X
Beckmann K, Duffy SW, Lynch J, Hiller J, Farshid G, Roder D(2015). Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects. Journal of Medical Screening vol. 22, (3) 127-135.
10.1177/0969141315573978
Beckmann K, Lynch J, Hiller J, Farshid G, Duffy S, Roder D(2015). Estimating over-diagnosis of breast cancer (Authors' Reply). International Journal of Cancer vol. 136, (10)
10.1002/ijc.29271
Marcus MW, Chen Y, Duffy SW, Field JK(2015). Impact of comorbidity on lung cancer mortality - A report from the liverpool lung project. Oncology Letters vol. 9, (4) 1902-1906.
10.3892/ol.2015.2916
Pashayan N, Duffy SW, Neal DE, Hamdy FC, Donovan JL, Martin RM, Harrington P, Benlloch S et al.(2015). Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis. Genetics in Medicine vol. 17, (10) 789-795.
10.1038/gim.2014.192
Sasieni PD, Smith RA, Duffy SW(2015). Informed decision-making and breast cancer screening. Journal of Medical Screening vol. 22, (4) 165-167.
10.1177/0969141315587344
Tabár L, Yen AMF, Wu WYY, Chen SLS, Chiu SYH, Fann JCY, Ku MMS, Smith RA et al.(2015). Insights from the breast cancer screening trials: How screening affects the natural history of breast cancer and implications for evaluating service screening programs. Breast Journal vol. 21, (1) 13-20.
10.1111/tbj.12354
Marcus MW, Chen Y, Raji OY, Duffy SW, Field JK(2015). LLPi:Liverpool Lung Project risk prediction model for lung cancer incidence. Cancer Prevention Research vol. 8, (6) 570-575.
10.1158/1940-6207.CAPR-14-0438
Geurts SME, Massat NJ, Duffy SW(2015). Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: Impact on colorectal cancer cases and deaths. British Journal of Cancer vol. 113, (1) 142-149.
10.1038/bjc.2015.76
Morrish OWE, Tucker L, Black R, Willsher P, Duffy SW, Gilbert FJ(2015). Mammographic breast density: Comparison of methods for quantitative evaluation. Radiology vol. 275, (2) 356-365.
10.1148/radiol.14141508
Tabár L, Chen H-H, Yen AM-F, Chen SL-S, Fann JC-Y, Chiu SY-H, Smith RA, Duffy SW(2015). Response to Miller et al. Breast Journal
10.1111/tbj.12439
Gilbert FJ, Tucker L, Gillan MGC, Willsher P, Cooke J, Duncan KA, Michell MJ, Dobson HM et al.(2015). The TOMMY trial: A comparison of TOMosynthesis with digital mammography in the UK NHS breast screening programme – A multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone. Health Technology Assessment vol. 19, (4) 1-166.
10.3310/hta19040
Massat NJ, Douglas E, Waller J, Wardle J, Duffy SW(2015). Variation in cervical and breast cancer screening coverage in England: A cross-sectional analysis to characterise districts with atypical behaviour. BMJ Open vol. 5, (7)
10.1136/bmjopen-2015-007735
https://qmro.qmul.ac.uk/xmlui/handle/123456789/9239
Massat NJ, Sasieni PD, Parmar D, Duffy SW(2014). An ongoing case-control study to evaluate the NHS Bowel Cancer Screening Programme. BMC Cancer vol. 14, (1)
10.1186/1471-2407-14-945
https://qmro.qmul.ac.uk/xmlui/handle/123456789/6803
Pashayan N, Duffy SW, Neal DE, Hamdy F, Donovan J, Martin RM, Harrington P, Benlloch S et al. (2014). Abstract 261: Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis. 261-261.
10.1158/1538-7445.am2014-261
Evans DG, Kesavan N, Lim Y, Gadde S, Hurley E, Massat NJ, Maxwell AJ, Ingham S et al.(2014). Erratum to: MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat vol. 147, (3)
10.1007/s10549-014-3106-4
Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, Gescher AJ, Key TJ et al.(2014). Risk determination and prevention of breast cancer. Breast Cancer Research vol. 16, (5)
10.1186/s13058-014-0446-2
Shankleman J, Massat NJ, Khagram L, Ariyanayagam S, Garner A, Khatoon S, Rainbow S, Rangrez S et al.(2014). Evaluation of a service intervention to improve awareness and uptake of bowel cancer screening in ethnically-diverse areas. Br J Cancer vol. 111, (7) 1440-1447.
10.1038/bjc.2014.363
https://qmro.qmul.ac.uk/xmlui/handle/123456789/17927
Morgan DAL, Bates T, Duffy SW, Pinder SE(2014). Addendum to BASOII Trial report. European Journal of Cancer vol. 50, (14) 2517-2518.
10.1016/j.ejca.2014.05.023
Morgan DAL, Bates T, Duffy SW, Pinder SE(2014). Addendum to BASOII Trial report. Eur J Cancer vol. 50, (14) 2517-2518.
10.1016/j.ejca.2014.05.023
Massat NJ, Tataru D, Parmar D, Sasieni PD, Duffy SW (2014). Case Fatality in Breast Cancer: Relative Effect of Attendance at Breast Screening and Cancer Treatment. Annals of Oncology. vol. 25,
10.1093/annonc/mdu438.52
Brains KE, Lifford K, Carter B, McRonald F, Yadegarfar G, Baldwin D, Weller D, Hansell DM et al. (2014). IMPACT OF LUNG CANCER SCREENING IN A HIGH-RISK POPULATION: THE UK LUNG SCREENING (UKLS) TRIAL. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE. vol. 21, S81-S81.
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.(2014). Therapeutic targeting of integrin αvβ6 in breast cancer. J Natl Cancer Inst vol. 106, (8)
10.1093/jnci/dju169
https://qmro.qmul.ac.uk/xmlui/handle/123456789/8829
Paci E, Broeders M, Hofvind S, Puliti D, Duffy SW, EUROSCREEN Working Group(2014). European breast cancer service screening outcomes: a first balance sheet of the benefits and harms. Cancer Epidemiol Biomarkers Prev vol. 23, (7) 1159-1163.
10.1158/1055-9965.EPI-13-0320
Marcus MW, Raji OY, Chen Y, Duffy SW, Field JK(2014). Factors associated with dropout in a lung cancer high‑risk cohort--the Liverpool lung project. Int J Oncol vol. 44, (6) 2146-2152.
10.3892/ijo.2014.2371
Duffy SW(2014). Recent results from the two Canadian breast screening trials. J Med Screen vol. 21, (2) 59-60.
10.1177/0969141314537615
Chen Y, Marcus MW, Niaz A, Duffy SW, Field JK(2014). MyLungRisk: A user-friendly, web-based calculator for risk assessment of lung cancer based on the validated Liverpool Lung Project risk prediction model. International Journal of Health Promotion and Education vol. 52, (3) 144-152.
10.1080/14635240.2014.888814
Duffy SW, Field JK, Allgood PC, Seigneurin A(2014). Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom. Br J Cancer vol. 110, (7) 1834-1840.
10.1038/bjc.2014.63
Seigneurin A, Field JK, Gachet A, Duffy SW(2014). A systematic review of the characteristics associated with recall rates, detection rates and positive predictive values of computed tomography screening for lung cancer. Ann Oncol vol. 25, (4) 781-791.
10.1093/annonc/mdt491
Duffy SW, Field JK, Allgood PC, Seigneurin A(2014). Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom. British Journal of Cancer vol. 110, (7) 1834-1840.
10.1038/bjc.2014.63
Baldwin DR, Hansell DM, Duffy SW, Field JK(2014). Lung cancer screening with low dose computed tomography. BMJ-BRITISH MEDICAL JOURNAL vol. 348, Article ARTN g1970,
10.1136/bmj.g1970
Baldwin DR, Hansell DM, Duffy SW, Field JK(2014). Lung cancer screening with low dose computed tomography: Now recommended in the US, but what about the UK?. BMJ (Online) vol. 348,
10.1136/bmj.g1970
Duffy SW(2014). Breast cancer screening causes more harm than good: No. J Prim Health Care vol. 6, (1) 81-82.
10.1071/hc14081
Poum A, Promthet S, Duffy SW, Parkin DM(2014). Factors Associated With Delayed Diagnosis of Breast Cancer in Northeast Thailand. JOURNAL OF EPIDEMIOLOGY vol. 24, (2) 102-108.
10.2188/jea.JE20130090
Evans DG, Thomas S, Caunt J, Roberts L, Howell A, Wilson M, Fox R, Sibbering DM et al.(2014). Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02). FAMILIAL CANCER vol. 13, (1) 13-21.
10.1007/s10689-013-9661-8
van der Waal D, Broeders MJM, Verbeek ALM, Duffy SW, Moss SM (2014). The case-control design and breast cancer screening effectiveness: Insights from the UK Age trial. EUROPEAN JOURNAL OF CANCER. vol. 50, S74-S74.
Duffy SW, Michalopoulos D, Sebuødegård S, Hofvind S(2014). Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution. J Med Screen vol. 21, (1) 24-29.
10.1177/0969141313517676
Dibden A, Offman J, Parmar D, Jenkins J, Slater J, Binysh K, McSorley J, Scorfield S et al.(2014). Reduction in interval cancer rates following the introduction of two-view mammography in the UK breast screening programme. Br J Cancer vol. 110, (3) 560-564.
10.1038/bjc.2013.778
https://qmro.qmul.ac.uk/xmlui/handle/123456789/25591
Field JK, Aberle DR, Altorki N, Baldwin DR, Dresler C, Duffy SW, Goldstraw P, Hirsch FR et al.(2014). The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations. J Thorac Oncol vol. 9, (2) 141-143.
10.1097/JTO.0000000000000060
Offman J, Myles J, Ariyanayagam S, Colorado Z, Sharp M, Cruice M, North BV, Shiel S et al.(2014). A telephone reminder intervention to improve breast screening information and access. Public Health
10.1016/j.puhe.2014.09.007
Beckmann KR, Lynch JW, Hiller JE, Farshid G, Houssami N, Duffy SW, Roder DM(2014). A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening. International Journal of Cancer
10.1002/ijc.29124
Offman J, Myles J, Ariyanayagam S, Colorado Z, Sharp M, Cruice M, North BV, Shiel S et al.(2014). A telephone reminder intervention to improve breast screening information and access. Public Health vol. 128, (11) 1017-1022.
10.1016/j.puhe.2014.09.007
Duffy SW(2014). Authors' reply. Breast cancer research : BCR vol. 16, (3)
10.1186/bcr3671
Zakharova N, Duffy S(2014). Early impact of mammographic screening in Western Siberia. Breast Journal vol. 20, (2) 219-220.
10.1111/tbj.12248
Duffy SW(2014). Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom. Breast Diseases vol. 25, (4) 315-316.
10.1016/j.breastdis.2014.10.010
Shankleman J, Massat NJ, Khagram L, Ariyanayagam S, Garner A, Khatoon S, Rainbow S, Rangrez S et al.(2014). Evaluation of a service intervention to improve awareness and uptake of bowel cancer screening in ethnically-diverse areas. British journal of cancer vol. 111, (7) 1440-1447.
10.1038/bjc.2014.363
Marcus MW, Raji OY, Chen Y, Duffy SW, Field JK(2014). Factors associated with dropout in a lung cancer high-risk cohort - The Liverpool lung project. International Journal of Oncology vol. 45, (6) 2146-2152.
10.3892/ijo.2014.2371
Gareth ED, Nisha K, Yit L, Soujanye G, Emma H, Massat NJ, Maxwell AJ, Sarah I et al.(2014). MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Research and Treatment
10.1007/s10549-014-2931-9
(2014). Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I. Breast cancer research : BCR vol. 16, (5)
10.1186/s13058-014-0451-5
https://qmro.qmul.ac.uk/xmlui/handle/123456789/10782
Chen Y, Marcus MW, Niaz A, Duffy SW, Field JK(2014). MyLungRisk: a user-friendly, web-based calculator for risk assessment of lung cancer based on the validated Liverpool Lung Project risk prediction model. International Journal of Health Promotion and Education
10.1080/14635240.2014.888814
McRonald FE, Yadegarfar G, Baldwin DR, Devaraj A, Brain KE, Eisen T, Holemans JA, Ledson M et al.(2014). The UK Lung Screen (UKLS): Demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prevention Research vol. 7, (3) 362-371.
10.1158/1940-6207.CAPR-13-0206
Tabár L, Dean PB, Chen THH, Yen AMF, Chiu SYH, Tot T, Smith RA, Duffy SW(2014). The impact of mammography screening on the diagnosis and management of early-phase breast cancer. Breast Cancer: A New Era in Management,
Field JK, Devaraj A, Baldwin DR, Holemans J, Screaton N, Ledson M, Rintoul RC, Nair A et al.(2014). UK Lung Cancer Screening trial (UKLS): Prevalence data at baseline. LUNG CANCER vol. 83, S24-S25.
10.1016/S0169-5002(14)70066-2
Smith R, Wu W-Y, Tabar L, Chen S-S, Yen A-F, Duffy S, Tot T, Chiu S-H et al.(2013). Abstract P4-03-07: The contribution of mammographic appearance, basal-like phenotype, and disease extent to prediction of breast cancer death.
10.1158/0008-5472.sabcs13-p4-03-07
Moore K, Thomas G, Duffy S, Warwick J, Gabe R, Chou P, Ellis I, Green A et al.(2013). Abstract P4-15-01: Integrin avb6 is a therapeutic target for high-risk breast cancer and enhances trastuzumab efficacy.
10.1158/0008-5472.sabcs13-p4-15-01
Smith R, Duffy S, Chen T-H, Yen A, Tabar L(2013). Abstract S1-10: Disparities in the estimates of benefits and harms from mammography: Are the numbers really different?.
10.1158/0008-5472.sabcs13-s1-10
Massat NJ, Sasieni PD, Parmar D, Duffy SW(2013). An ongoing case-control study to evaluate the NHS breast screening programme. BMC Cancer vol. 13,
10.1186/1471-2407-13-596
Field JK, Hansell DM, Duffy SW, Baldwin DR(2013). CT screening for lung cancer: countdown to implementation. LANCET ONCOLOGY vol. 14, (13) E591-E600.
10.1016/S1470-2045(13)70293-6
Duffy SW, Chen TH-H, Smith RA, Yen AM-F, Tabar L(2013). Real and artificial controversies in breast cancer screening. Breast Cancer Management vol. 2, (6) 519-528.
10.2217/bmt.13.53
Field JK, Devaraj A, Baldwin DR, Holemans J, Screaton N, Ledson M, Rintoul RC, Nair A et al.(2013). UK LUNG CANCER SCREENING TRIAL (UKLS): BASE LINE DATA. JOURNAL OF THORACIC ONCOLOGY vol. 8, S685-S685.
Moore KM, Thomas GJ, Duffy SW, Warwick J, Gabe R, Chou P, Ellis IO, Green AR et al.(2013). Abstract B046: Therapeutic targeting of integrin αvβ6 in high-risk breast cancer. b046-b046.
10.1158/1557-3125.advbc-b046
Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, Blaydes JP, Brennan K et al.(2013). Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Research vol. 15, (5)
10.1186/bcr3493
Field JK, Van Klaveren R, Pedersen JH, Pastorino U, Paci E, Becker N, Infante M, Oudkerk M et al.(2013). European randomized lung cancer screening trials: Post NLST. Journal of Surgical Oncology vol. 108, (5) 280-286.
10.1002/jso.23383
Field JK, Chen Y, Marcus MW, McRonald FE, Raji OY, Duffy SW(2013). The contribution of risk prediction models to early detection of lung cancer. Journal of Surgical Oncology vol. 108, (5) 304-311.
10.1002/jso.23384
Paci E, Smith R, Broeders M, Duffy S(2013). Complex statistical techniques cannot overcome weak methodology in the evaluation of breast cancer mortality trends. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE vol. 106, (9) 346-346.
10.1177/0141076813501807
Zakharova N, Duffy S, Pyankin S, Pestryakova A (2013). Regional experience of the mammographic screening implementation in Western Siberia. EUROPEAN JOURNAL OF CANCER. vol. 49, S323-S323.
Offman J, Wilson M, Lamont M, Birke H, Kutt E, Marriage S, Loughrey Y, Hudson S et al.(2013). A randomised trial of weekend and evening breast screening appointments. Br J Cancer vol. 109, (3) 597-602.
10.1038/bjc.2013.377
https://qmro.qmul.ac.uk/xmlui/handle/123456789/25549
Blamey RW, Bates T, Chetty U, Duffy SW, Ellis IO, George D, Mallon E, Mitchell MJ et al.(2013). Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. EUROPEAN JOURNAL OF CANCER vol. 49, (10) 2294-2302.
10.1016/j.ejca.2013.02.031
Duffy SW, Parmar D(2013). Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res vol. 15, (3)
10.1186/bcr3427
https://qmro.qmul.ac.uk/xmlui/handle/123456789/5660
Field JK, Baldwin D, Devaraj A, Brain K, Eisen T, Holemans J, Ledson M, Screaton N et al. (2013). United Kingdom lung cancer screening trial (UKLS): First 88897 approaches. CANCER RESEARCH. vol. 73,
10.1158/1538-7445.AM2013-3631
Field JK, Raji OY, Duffy SW(2013). Predictive Accuracy of the Liverpool Lung Project Risk Model RESPONSE. ANNALS OF INTERNAL MEDICINE vol. 158, (7) 568-569.
10.7326/0003-4819-158-7-201304020-00015
Field JK, Raji OY, Duffy SW(2013). RE: Predictive accuracy of the Liverpool lung project risk model. Annals of Internal Medicine vol. 158, (7) 568-569.
10.7326/0003-4819-158-7-201304020-00015
Paci E, Broeders M, Hofvind S, Duffy SW, Grp EW(2013). The benefits and harms of breast cancer screening. LANCET vol. 381, (9869) 800-801.
10.1016/S0140-6736(13)60622-4
Duffy SW, Mackay J, Thomas S, Anderson E, Chen TH, Ellis I, Evans G, Fielder H et al.(2013). Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Health Technol Assess vol. 17, (11) vii-95.
10.3310/hta17110
Duffy SW(2013). In Reply: The benefits and harms of breast cancer screening. The Lancet vol. 381, (9869)
Nagtegaal ID, Duffy SW(2013). Reduction in rate of node metastases with breast screening: consistency of association with tumor size. BREAST CANCER RESEARCH AND TREATMENT vol. 137, (3) 653-663.
10.1007/s10549-012-2384-y
Field JK, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K et al.(2013). Authors' response. THORAX vol. 68, (1) 105-105.
10.1136/thoraxjnl-2012-202442
Paci E, Broeders M, Hofvind S, Duffy SW(2013). In Reply: The benefits and harms of breast cancer screening. The Lancet vol. 381, (9869) 800-801.
10.1016/S0140-6736(13)60622-4
Klevesath MB, Pantel K, Agbaje O, Provenzano E, Wishart GC, Gough P, Pinder SE, Duffy S et al.(2013). Patterns of metastatic spread in early breast cancer. Breast vol. 22, (4) 449-454.
10.1016/j.breast.2013.04.017
Field JK, Oudkerk M, Pedersen JH, Duffy SW(2013). Prospects for population screening and diagnosis of lung cancer. The Lancet vol. 382, (9893) 732-741.
10.1016/S0140-6736(13)61614-1
Massat NJ, Moss SM, Halloran SP, Duffy SW(2013). Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences. J Med Screen vol. 20, (3) 125-148.
10.1177/0969141313501292
Field JK, Chen Y, Marcus MW, Mcronald FE, Raji OY, Duffy SW(2013). The contribution of risk prediction models to early detection of lung cancer. Journal of Surgical Oncology
10.1002/jso.23384
McRonald F, Baldwin DR, Devaraj A, Brain K, Eisen T, Holeman J, Ledson M, Screaton N et al.(2013). The uniqueness of the United Kingdom Lung Cancer Screening trial (UKLS) - a population screening study. LUNG CANCER vol. 79, S28-S29.
10.1016/S0169-5002(13)70081-3
Warwick J, Will O, Allgood P, Miller R, Duffy S, Greenberg D(2013). Variation in colorectal cancer treatment and survival: a cohort study covering the East Anglia region. Colorectal Dis vol. 15, (10) 1243-1252.
10.1111/codi.12308
Yen AM-F, Duffy SW, Chen TH-H, Chen L-S, Chiu SY-H, Fann JC-Y, Wu WY-Y, Su C-W et al.(2012). Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening. CANCER vol. 118, (23) 5728-5732.
10.1002/cncr.27580
Gao F, Machin D, Chow K-Y, Sim Y-F, Duffy SW, Matchar DB, Goh C-H, Chia K-S(2012). Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study). BMC CANCER vol. 12, Article ARTN 529,
10.1186/1471-2407-12-529
Beral V, Bull D, Pirie K, Reeves G, Peto R, Skegg D, LaVecchia C, Magnusson C et al.(2012). Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. LANCET ONCOLOGY vol. 13, (11) 1141-1151.
10.1016/S1470-2045(12)70425-4
Zakharova NA, Duffy SW, Mackay J, Kotlyarov EV, Filimonov AV, Barinov K, Gromut I, Belan EV(2012). 1451P Five-Year Results of the Breast Cancer Screening Programme in UGRA. Annals of Oncology vol. 23,
10.1016/s0923-7534(20)34009-6
Zakharova NA, Duffy SW, Mackay J, Kotlyarov EV, Filimonov AV, Barinov K, Gromut I, Belan EV (2012). FIVE-YEAR RESULTS OF THE BREAST CANCER SCREENING PROGRAMME IN UGRA. ANNALS OF ONCOLOGY. vol. 23, 470-470.
Raji OY, Duffy SW, Agbaje OF, Baker SG, Christiani DC, Cassidy A, Field JK(2012). Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer A Case-Control and Cohort Validation Study. ANNALS OF INTERNAL MEDICINE vol. 157, (4) 242-+.
10.7326/0003-4819-157-4-201208210-00004
Maurice A, Evans DG, Affen J, Greenhalgh R, Duffy SW, Howell A(2012). Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: Further evidence of benefit. INTERNATIONAL JOURNAL OF CANCER vol. 131, (2) 417-425.
10.1002/ijc.26394
Field J, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K et al.(2012). Tuberculosis through the rose tinted spectacles of the EBUS endoscopist: be aware of the bias response. THORAX vol. 67, (7) 650-650.
10.1136/thoraxjnl-2011-200822
Tabár L, Smith RA, Chen THH, Duffy SW(2012). Response. Radiology vol. 263, (1)
10.1148/radiol.11111988
Smith RA, Duffy SW, Tabar L(2012). Breast Cancer Screening: The Evolving Evidence. ONCOLOGY-NEW YORK vol. 26, (5) 471-486.
Smith RA, Duffy SW, Tabár L(2012). Breast cancer screening: the evolving evidence. Oncology (Williston Park, N.Y.) vol. 26, (5)
Duffy SW, Yen AM-F, Chen TH-H, Chen SL-S, Chiu SY-H, Fan JJ-Y, Smith RA, Vitak B et al.(2012). Long-term benefits of breast screening. Breast Cancer Management vol. 1, (1) 31-38.
10.2217/bmt.12.8
Britton P, Warwick J, Wallis MG, O'Keeffe S, Taylor K, Sinnatamby R, Barter S, Gaskarth M et al.(2012). Measuring the accuracy of diagnostic imaging in symptomatic breast patients: team and individual performance. BRITISH JOURNAL OF RADIOLOGY vol. 85, (1012) 415-422.
10.1259/bjr/32906819
Tabar L, Smith RA, Chen THH, Duffy SW(2012). Swedish Two-County Trial: Total Mortality Data Are Needed Response. RADIOLOGY vol. 263, (1) 308-308.
Tabár L, Dean PB, Tony Chen HH, Duffy SW, Yen AMF, Chiu SYH(2012). Breast Imaging: Mammography. Principles and Practice of Surgical Oncology: A Multidisciplinary Approach to Difficult Problems,
Tabar L, Lindhe N, Yen AMF, Chen THH, Chiu SYH, Fann JCY, Chen SLS, Wu GHM et al.(2012). Radiotherapy After Surgery for Small Breast Cancers of Stellate Appearance. Imaging of the Breast - Technical Aspects and Clinical Implication,
Pinker-Domenig K, Bogner W, Gruber S, Bickel H, Duffy S, Schernthaner M, Dubsky P, Pluschnig U et al.(2012). High resolution MRI of the breast at 3 T: which BI-RADSA (R) descriptors are most strongly associated with the diagnosis of breast cancer?. EUROPEAN RADIOLOGY vol. 22, (2) 322-330.
10.1007/s00330-011-2256-6
Duffy S(2012). Misplaced criticism of breast screening research. J R Soc Med vol. 105, (2) 53-54.
10.1258/jrsm.2011.110311
Tabár L, Smith RA, Chen THH, Duffy SW(2012). Response. Radiology vol. 262, (2) 730-731.
10.1148/radiol.11111756
Tabar L, Smith RA, Chen TH-H, Duffy SW(2012). The Two-County Breast Screening Trial Cannot Provide a Reliable Estimate of the Effect of Breast Cancer Screening Response. RADIOLOGY vol. 262, (2) 730-731.
Field J, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K et al.(2012). Authors' response. Thorax vol. 67, (7)
10.1136/thoraxjnl-2011-200822
Hamajima N, Hirose K, Tajima K, Rohan T, Friedenreich CM, Calle EE, Gapstur SM, Patel AV et al.(2012). Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. The Lancet Oncology vol. 13, (11) 1141-1151.
10.1016/S1470-2045(12)70425-4
Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E, Grp EUROSCREENW(2012). Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. JOURNAL OF MEDICAL SCREENING vol. 19, 42-56.
10.1258/jms.2012.012082
Hellquist BN, Duffy SW, Nystrom L, Jonsson H(2012). Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden. JOURNAL OF MEDICAL SCREENING vol. 19, (1) 14-19.
10.1258/jms.2012.011104
Cheol Kim D, Thorat MA, Lee MR, Cho SH, Vasiljevi¿ N, Scibior-Bentkowska D, Wu K, Ahmad AS et al.(2012). Quantitative DNA methylation and recurrence of breast cancer: a study of 30 candidate genes. Cancer Biomark vol. 11, (2-3) 75-88.
10.3233/CBM-2012-0266
Duffy S, Williams D, Stevens T, Kegel I, Jansen J, Cesar P, Healey PGT(2012). Remote Music Tuition. Proceedings of 9th Sound and Music Computing Conference333-338.
Brentnall AR, Duffy SW, Baio G, Raine R(2012). Strategy for power calculation for interactions: application to a trial of interventions to improve uptake of bowel cancer screening. Contemp Clin Trials vol. 33, (1) 213-217.
10.1016/j.cct.2011.09.021
Ancelle-Park R, Armaroli P, Ascunce N, Bisanti L, Bellisario C, Broeders M, Cogo C, de Koning H et al.(2012). Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. JOURNAL OF MEDICAL SCREENING vol. 19, 5-13.
10.1258/jms.2012.012077
Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, Massat N, Duffy S et al.(2012). The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen vol. 19 Suppl 1, 14-25.
10.1258/jms.2012.012078
Smith R, Duffy S(2011). S4-1: Overdiagnosis in Breast Cancer Screening: Methodological Considerations of Current Estimates.
10.1158/0008-5472.sabcs11-s4-1
Assi V, Warwick J, Cuzick J, Duffy SW(2011). Clinical and epidemiological issues in mammographic density. Nat Rev Clin Oncol vol. 9, (1) 33-40.
10.1038/nrclinonc.2011.173
Brentnall AR, Duffy SW, Crowder MJ, Gillan MGC, Astley SM, Wallis MG, James J, Boggis CRM et al.(2011). A METHOD FOR EXPLORATORY REPEATED-MEASURES ANALYSIS APPLIED TO A BREAST-CANCER SCREENING STUDY. ANNALS OF APPLIED STATISTICS vol. 5, (4) 2448-2469.
10.1214/11-AOAS481
https://qmro.qmul.ac.uk/xmlui/handle/123456789/11421
Chen M-K, Hung H-F, Duffy S, Yen AM-F, Chen H-H(2011). Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination. J Eval Clin Pract vol. 17, (6) 1050-1058.
10.1111/j.1365-2753.2010.01453.x
Duffy S(2011). A community creating their own rules on foursquare. Proceedings - 2011 Workshop on Mobile and Online Social Networks, MOSN 20117-12.
10.1109/MOSN.2011.6060786
Jonsson H, Holmstrom B, Duffy SW, Stattin P(2011). Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden. INT J CANCER vol. 129, (8) 1881-1888.
10.1002/ijc.25846
Zakharova N, Duffy SW, Mackay J, Kotlyarov E, Filimonov A, Belousov V (2011). Current Results of the Breast Cancer Screening Programme After Four Years Implementation in Khanty-Mansiysky Autonomous Okrug - Ugra. EUROPEAN JOURNAL OF CANCER. vol. 47, S258-S258.
10.1016/s0959-8049(11)71194-7
Kopans DB, Smith RA, Duffy SW(2011). Mammographic Screening and "Overdiagnosis". RADIOLOGY vol. 260, (3) 616-620.
10.1148/radiol.11110716
Tabar L, Vitak B, Chen THH, Yen AMF, Cohen A, Tot T, Chiu SYH, Chen SLS et al.(2011). Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades. RADIOLOGY vol. 260, (3) 658-663.
10.1148/radiol.11110469
Field JK, Baldwin D, Brain K, Devaraj A, Eisen T, Duffy SW, Hansell DM, Kerr K et al.(2011). CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. THORAX vol. 66, (8) 736-737.
10.1136/thoraxjnl-2011-200351
Field JK, Raji OY, Cassidy A, Mimnagh C, Hughes J, Warburton C, Giles T, Liloglou T et al.(2011). A PILOT LUNG CANCER EARLY DETECTION STUDY IN A PRIMARY CARE PRACTICE IN KNOWSLEY, MERSEYSIDE: THE LIVERPOOL LUNG PROJECT PRIMARY CARE IMPLEMENTATION PROGRAMME (LLP-PCIP). J THORAC ONCOL vol. 6, (6) S1393-S1393.
Uhry Z, Hedelin G, Colonna M, Asselain B, Arveux P, Exbrayat C, Guldenfelds C, Soler-Michel P et al.(2011). Modelling the effect of breast cancer screening on related mortality using French data. CANCER EPIDEMIOL vol. 35, (3) 235-242.
10.1016/j.canep.2010.10.009
Uhry Z, Hedelin G, Colonna M, Duffy S(2011). Reply to: Lost opportunity to usefully examine French breast cancer screening mortality. CANCER EPIDEMIOL vol. 35, (3) 307-308.
10.1016/j.canep.2011.02.007
Field JK, Duffy S, Baldwin D, Brain K, Eisen T, Hands CJD, Kerr KM, Page R et al.(2011). UNITED KINGDOM LUNG CANCER SCREENING (UKLS) TRIAL. J THORAC ONCOL vol. 6, (6) S1382-S1383.
Allgood PC, Duffy SW, Kearins O, O'Sullivan E, Tappenden N, Wallis MG, Lawrence G(2011). Explaining the difference in prognosis between screen-detected and symptomatic breast cancers. Br J Cancer vol. 104, (11) 1680-1685.
10.1038/bjc.2011.144
Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, Easton DF, Eeles R et al.(2011). Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. BRIT J CANCER vol. 104, (10) 1656-1663.
10.1038/bjc.2011.118
Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RML(2011). Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst vol. 103, (9) 744-752.
10.1093/jnci/djr079
Nagtegaal ID, Allgood PC, Duffy SW, Kearins O, Sullivan EO, Tappenden N, Wallis M, Lawrence G(2011). Prognosis and pathology of screen-detected carcinomas: how different are they?. Cancer vol. 117, (7) 1360-1368.
10.1002/cncr.25613
Perry NM, Patani N, Milner SE, Pinker K, Mokbel K, Allgood PC, Duffy SW(2011). The impact of digital mammography on screening a young cohort of women for breast cancer in an urban specialist breast unit. Eur Radiol vol. 21, (4) 676-682.
10.1007/s00330-010-1968-3
Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK(2011). UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax vol. 66, (4) 308-313.
10.1136/thx.2010.152066
Pashayan N, Pharoah P, Tabar L, Neal DE, Martin RM, Donovan J, Hamdy F, Duffy SW(2011). Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence. CANCER EPIDEMIOL vol. 35, (2) 139-144.
10.1016/j.canep.2010.07.012
Pashayan N, Pharoah P, Neal DE, Hamdy F, Donovan J, Martin RM, Greenberg D, Duffy SW(2011). PSA-detected prostate cancer and the potential for dedifferentiation-estimating the proportion capable of progression. INT J CANCER vol. 128, (6) 1462-1470.
10.1002/ijc.25471
Duffy SW, Mackay J(2011). Elementary flaws in the FH01 study - Authors' reply. Lancet Oncol vol. 12, (3) 215-216.
10.1016/S1470-2045(11)70048-1
Duffy SW, Mackay J(2011). Elementary flaws in the FH01 study Reply. LANCET ONCOL vol. 12, (3) 215-216.
10.1016/S1470-2045(11)70048-1
Wong CS, Lim GH, Gao F, Jakes RW, Offman J, Chia KS, Duffy SW(2011). Mammographic density and its interaction with other breast cancer risk factors in an Asian population. BRIT J CANCER vol. 104, (5) 871-874.
10.1038/sj.bjc.6606085
https://qmro.qmul.ac.uk/xmlui/handle/123456789/25664
Hellquist BN, Duffy SW, Abdsaleh S, Bjorneld L, Bordas P, Tabar L, Vitak B, Zackrisson S et al.(2011). Effectiveness of Population-Based Service Screening With Mammography for Women Ages 40 to 49 Years Evaluation of the Swedish Mammography Screening in Young Women (SCRY) Cohort. CANCER-AM CANCER SOC vol. 117, (4) 714-722.
10.1002/cncr.25650
Hellquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabár L, Viták B, Zackrisson S et al.(2011). Effectiveness of population-based service screening with mammography for women ages 40 to 49 years. Cancer vol. 117, (4) 714-722.
10.1002/cncr.25650
Zakharova N, Duffy SW, Mackay J, Kotlyarov E(2011). The introduction of a breast cancer screening programme in a region with a population at medium risk for developing breast cancer: Khanty-Mansiysky autonomous Okrug - Ugra (Russian Federation). ecancermedicalscience vol. 5, (1)
10.3332/ecancer.2011.195
Duffy SW, Smith RA(2011). More on screening mammography [1]. New England Journal of Medicine vol. 364, (3)
10.1056/NEJMc1011881
Clark SE, Warwick J, Carpenter R, Bowen RL, Duffy SW, Jones JL(2011). Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. Br J Cancer vol. 104, (1) 120-127.
10.1038/sj.bjc.6606021
Duffy SW, Treasure FP(2011). Potential surrogate endpoints in cancer research--some considerations and examples. Pharm Stat vol. 10, (1) 34-39.
10.1002/pst.406
Gilbert FJ, Gillan MGC, Michell MJ, Young KC, Dobson HM, Cooke J, Purushothaman H, Lim YY et al. (2011). TOMMY Trial (a comparison of tomosynthesis with digital mammography in the UK NHS breast screening programme) setting up a multicentre imaging trial. BREAST CANCER RESEARCH. vol. 13,
10.1186/bcr2980
Beral V, Alexander M, Duffy S, Ellis IO, Given-Wilson R, Holmberg L, Moss SM, Ramirez A et al.(2011). The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer. JOURNAL OF MEDICAL SCREENING vol. 18, (4) 210-212.
10.1258/jms.2011.011134
Chang J-C, Chen TH-H, Duffy SW, Yen AM-F, Chen SL-S(2010). Decision modelling of economic evaluation of intervention programme of breast cancer. J Eval Clin Pract vol. 16, (6) 1282-1288.
10.1111/j.1365-2753.2009.01329.x
Duffy SW, Mackay J, Thomas S, Anderson E, Evans DG, Fielder H, Fox R, Gray J et al.(2010). Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. LANCET ONCOL vol. 11, (12) 1127-1134.
10.1016/S1470-2045(10)70263-1
Raji OY, Duffy SW, Xinarianos G, Liloglou T, Young RP, Field JK (2010). Representing Epistasis Effects of Susceptibility SNPs in a Risk Prediction Model for Lung Cancer. GENETIC EPIDEMIOLOGY. vol. 34, 979-980.
Zakharova NA, Duffy SW, Mackey J, Kotlyarov YV(2010). Evaluation of screening program for early diagnosis of breast cancer in the Khanty-Mansy Autonomous Region - Yugra. Voprosy Onkologii vol. 56, (5) 609-612.
Nagtegaal ID, Allgood PC, Duffy SW, Kearins O, Sullivan EO, Tappenden N, Wallis M, Lawrence G(2010). Prognosis and pathology of screen-detected carcinomas: how different are they?. Cancer
10.1002/cncr.25613
Stone J, Ding J, Warren RML, Duffy SW(2010). Predicting breast cancer risk using mammographic density measurements from both mammogram sides and views. BREAST CANCER RES TR vol. 124, (2) 551-554.
10.1007/s10549-010-0976-y
Chen LS, Yen AMF, Duffy SW, Tabar L, Lin WC, Chen HH(2010). Computer-aided System of Evaluation for Population-based All-in-One Service Screening (CASE-PASS): From Study Design to Outcome Analysis with Bias Adjustment. ANN EPIDEMIOL vol. 20, (10) 786-796.
10.1016/j.annepidem.2010.06.003
Yen AMF, Chen THH, Duffy SW, Chen CD(2010). Incorporating frailty in a multi-state model: application to disease natural history modelling of adenoma-carcinoma in the large bowel. STAT METHODS MED RES vol. 19, (5) 529-546.
10.1177/0962280209359862
Duffy SW, Sasieni P, Olsen AH, Cafferty FH(2010). Modelling the likely effect of the increase of the upper age limit from 70 to 73 for breast screening in the UK National Programme. Stat Methods Med Res vol. 19, (5) 547-555.
10.1177/0962280209358140
Uhry Z, Hedelin G, Colonna M, Asselain B, Arveux P, Rogel A, Exbrayat C, Guldenfels C et al.(2010). Multi-state Markov models in cancer screening evaluation: a brief review and case study. STAT METHODS MED RES vol. 19, (5) 463-486.
10.1177/0962280209359848
Zakharova NA, Duffy SW, Mackay J, Kotlyarov EV (2010). THE EVALUATION OF THE BREAST CANCER SCREENING PROGRAMME IN THE KHANTY-MANSIYSKY AUTONOMOUS OKRUG - UGRA, WESTERN SIBERIA. ANNALS OF ONCOLOGY. vol. 21, 349-349.
Atkin W, Wardle J, Kralj-Hans I, Duffy S(2010). Flexible sigmoidoscopy to prevent colorectal cancer Reply. LANCET vol. 376, (9744) 871-872.
10.1016/S0140-6736(10)61407-9
Atkin W, Kralj-Hans I, Wardle J, Duffy S(2010). Colorectal cancer screening: Randomised trials of flexible sigmoidoscopy. BMJ (Online) vol. 341, (7770)
10.1136/bmj.c4618
Atkin W, Kralj-Hans I, Wardle J, Duffy S(2010). Colorectal cancer screening Randomised trials of flexible sigmoidoscopy. BRITISH MEDICAL JOURNAL vol. 341, Article ARTN c4618,
10.1136/bmj.c4618
James JJ, Gilbert FJ, Wallis MG, Gillan MGC, Astley SM, Boggis CRM, Agbaje OF, Brentnall AR et al.(2010). Mammographic Features of Breast Cancers at Single Reading with Computer-aided Detection and at Double Reading in a Large Multicenter Prospective Trial of Computer-aided Detection: CADET II. Radiology vol. 256, (2) 379-386.
10.1148/radiol.10091899
Wishart GC, Warwick J, Pitsinis V, Duffy S, Britton PD(2010). Measuring performance in clinical breast examination. BRIT J SURG vol. 97, (8) 1246-1252.
10.1002/bjs.7108
D'Amelio AM, Cassidy A, Asomaning K, Raji OY, Duffy SW, Field JK, Spitz MR, Christiani D et al.(2010). Comparison of discriminatory power and accuracy of three lung cancer risk models. BRIT J CANCER vol. 103, (3) 423-429.
10.1038/sj.bjc.6605759
Wessler JD, Pashayan N, Greenberg DC, Duffy SW(2010). Age-period-cohort analysis of colorectal cancer in East Anglia, 1971-2005. CANCER EPIDEMIOL vol. 34, (3) 232-237.
10.1016/j.canep.2010.03.012
Duffy SW, Tabar L, Olsen AH(2010). Erratum: Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England (Journal of Medical Screening (2010) 17 (25-30)). Journal of Medical Screening vol. 17, (2)
10.1258/jms.2010.010350
Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JMA, Parkin DM, Wardle J et al.(2010). Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet vol. 375, (9726) 1624-1633.
10.1016/S0140-6736(10)60551-X
Atkin WS, Cuzick J, Duffy SW, Edwards R, Hart A, Kralj-Hans I, Northover JM, Wardle J et al.(2010). 283 UK Flexible Sigmoidoscopy Screening Trial: Colorectal Cancer Incidence and Mortality Rates at 11 Years After a Single Screening Examination. Gastroenterology vol. 138, (5) s-53.
10.1016/s0016-5085(10)60241-7
Chiu SY-H, Duffy S, Yen AM-F, Tabár L, Smith RA, Chen H-H(2010). Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev vol. 19, (5) 1219-1228.
10.1158/1055-9965.EPI-09-1028
Raji OY, Agbaje OF, Duffy SW, Cassidy A, Field JK(2010). Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project. Cancer Prev Res (Phila) vol. 3, (5) 664-669.
10.1158/1940-6207.CAPR-09-0141
Atkin WS, Cuzick J, Duffy SW, Edwards R, Hart A, Kralj-Hans I, Northover JM, Wardle J et al. (2010). UK Flexible Sigmoidoscopy Screening Trial: Colorectal Cancer Incidence and Mortality Rates at 11 Years After a Single Screening Examination. GASTROENTEROLOGY. vol. 138, S53-S53.
Pinker K, Milner S, Mokbel K, Duffy S, Perry NM (2010). Mammographic density decreases with age as assessed by an objective integral automated breast density measurement system. EJC SUPPLEMENTS. vol. 8, 233-233.
10.1016/s1359-6349(10)70617-0
Duffy SW, Greenberg DC, Chou P, Brown CH, Purushotham AD, Wishart GC(2010). Reply to Explaining variations in survival in breast cancer in the Eastern Region of England. Ann Oncol vol. 21, (3)
10.1093/annonc/mdp572
Wishart GC, Greenberg DC, Chou P, Brown CH, Duffy S, Purushotham AD(2010). Treatment and survival in breast cancer in the Eastern Region of England. ANN ONCOL vol. 21, (2) 291-296.
10.1093/annonc/mdp301
Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen THH, Yen AMF, Smith RA(2010). Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen vol. 17, (1) 25-30.
10.1258/jms.2009.009094
Pinker K, Perry N, Milner S, Mokbel K, Duffy S (2010). Accuracy of breast cancer detection with full-field digital mammography and integral computer-aided detection correlated with breast density as assessed by a new automated volumetric breast density measurement system. BREAST CANCER RESEARCH. vol. 12,
10.1186/bcr2657
Lip G, Zakharova N, Duffy SW, Gillan MGC, Gilbert FJ (2010). Breast density as a predictor of breast cancer risk. BREAST CANCER RESEARCH. vol. 12,
10.1186/bcr2654
Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA(2010). Cancer mortality in the 50-69 year age group before and after screening. J Med Screen vol. 17, (3) 159-160.
10.1258/jms.2010.010083
Warwick J, Oram D, Covens A, Duffy S, Reynolds K(2010). Defining the surgical management of suspected early-stage ovarian cancer by estimating patient numbers through alternative management strategies. BJOG-INT J OBSTET GY vol. 117, (1) 114-116.
10.1111/j.1471-0528.2009.02429.x
Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA(2010). Duffy and colleagues reply. J Med Screen vol. 17, (2)
10.1258/jms.2010.010060
Duffy SW(2010). Epidemiology of female breast cancer. Breast Cancer,
Pinker K, Perry N, Milner S, Mokbel K, Duffy S (2010). Sensitivity of integral computer-aided detection with full-field digital mammography for detection of breast cancer according to different histopathological tumor types and appearances. BREAST CANCER RESEARCH. vol. 12,
10.1186/bcr2666
Mayerhoefer M, Perry N, Milner S, Mokbel K, Duffy S, Pinker K (2010). Texture analysis applied to full-field digital mammography: ability to discriminate between invasive ductal and invasive lobular breast cancer - preliminary results. BREAST CANCER RESEARCH. vol. 12,
10.1186/bcr2665
Stone J, Ding J, Warren RML, Duffy SW, Hopper JL(2010). Using mammographic density to predict breast cancer risk: dense area or percentage dense area. BREAST CANCER RES vol. 12, (6) Article R97,
10.1186/bcr2778
Pinker K, Perry N, Milner S, Mokbel K, Duffy S (2010). Validation of a new automated volumetric breast density measurement system as a marker of breast cancer risk. BREAST CANCER RESEARCH. vol. 12,
10.1186/bcr2648
Dawson SJ, Duffy SW, Blows FM, Driver KE, Provenzano E, LeQuesne J, Greenberg DC, Pharoah P et al.(2009). Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival. BRIT J CANCER vol. 101, (8) 1338-1344.
10.1038/sj.bjc.6605317
Duffy SW, Raji OY, Agbaje OF, Allgood PC, Cassidy A, Field JK(2009). Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer. Expert Rev Anticancer Ther vol. 9, (10) 1467-1472.
10.1586/era.09.87
Duffy SW(2009). Cost of a 5-year lung cancer survivor. BRIT J CANCER vol. 101, (6) 881-881.
10.1038/sj.bjc.6605254
WALD NJ, Law MR, Duffy SW(2009). Lives saved by breast cancer screening. BMJ: British Medical Journal vol. 339,
10.1136/bmj.b3359
Zakharova N, Mackay J, Duffy S, Belyavsky A, Filimonov A, Kotlyarov Y (2009). Breast cancer screening program in Khanty-Mansiysk autonomous Okrug - Yugra. EJC SUPPLEMENTS. vol. 7, 314-315.
10.1016/s1359-6349(09)71074-2
Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW(2009). Early detection of second breast cancers improves prognosis in breast cancer survivors. ANN ONCOL vol. 20, (9) 1505-1510.
10.1093/annonc/mdp037
Raji OY, Agbaje OF, Duffy SW, Field JK(2009). The predictive ability of LLP lung cancer risk model with and without seizure 6-Like (SEZ6L) gene. J THORAC ONCOL vol. 4, (9) S408-S409.
(2009). Breast screening saves lives. BMJ (Clinical research ed.) vol. 339,
10.1136/bmj.b2922
Warwick J, Vardaki E, Fattizzi N, McNeish I, Jeyarajah A, Oram D, Hassan L, Covens A et al.(2009). Defining the surgical management of suspected early-stage ovarian cancer by estimating patient numbers through alternative management strategies. BJOG vol. 116, (9) 1225-1241.
10.1111/j.1471-0528.2009.02213.x
Wald NJ, Law MR, Duffy SW(2009). Breast screening Breast screening saves lives. BRIT MED J vol. 339, Article b2922,
10.1136/bmj.b2922
WALD NJ, Law MR, Duffy SW(2009). Reduction in breast cancer mortality from mammographic screening. BMJ: British Medical Journal vol. 338,
10.1136/bmj.b2561
Lawrence G, Wallis M, Allgood P, Nagtegaal ID, Warwick J, Cafferty FH, Houssami N, Kearins O et al.(2009). Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias. BREAST CANCER RES TR vol. 116, (1) 179-185.
10.1007/s10549-008-0100-8
Britton P, Duffy SW, Sinnatamby R, Wallis MG, Barter S, Gaskarth M, O'Neill A, Caldas C et al.(2009). One-stop diagnostic breast clinics: how often are breast cancers missed?. BRIT J CANCER vol. 100, (12) 1873-1878.
10.1038/sj.bjc.6605082
Duffy SW(2009). Commentary on 'what is the point: will screening mammography save my life?' by Keen and Keen. BMC Med Inform Decis Mak vol. 9,
10.1186/1472-6947-9-19
Cafferty FH, Sasieni PD, Duffy SW(2009). A deterministic model for estimating the reduction in colorectal cancer incidence due to endoscopic surveillance. Stat Methods Med Res vol. 18, (2) 163-182.
10.1177/0962280208089091
Pashayan N, Duffy SW, Pharoah P, Greenberg D, Donovan J, Martin RM, Hamdy F, Neal DE(2009). Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening. BRIT J CANCER vol. 100, (7) 1198-1204.
10.1038/sj.bjc.6604973
MacMahon S, Baigent C, Duffy S, Rodgers A, Tominaga S, Chambless L, De Backer G, De Bacquer D et al.(2009). Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. The Lancet vol. 373, (9669) 1083-1096.
10.1016/S0140-6736(09)60318-4
Cuzick J, Warwick J, Pinney L, Warren R, Cawthorn S, Howell A, Duffy S (2009). Change in breast density as a biomarker of breast cancer risk reduction; results from IBIS-1. CANCER RESEARCH. vol. 69, 77S-78S.
Duffy SW, Lynge E, Jonsson H(2009). Reply: Estimation of lead-time and overdiagnosis in breast cancer screening. BRIT J CANCER vol. 100, (1) 220-220.
10.1038/sj.bjc.6604824
Holmberg L, Duffy SW, Yen AMF, Tabar L, Vitak B, Nystrom L, Frisell J(2009). Differences in endpoints between the Swedish W-E (two county) trial of mammographic screening and the Swedish overview: methodological consequences. J MED SCREEN vol. 16, (2) 73-80.
10.1258/jms.2009.008103
Field JK, Liloglou T, Niaz A, Bryan J, Cassidy A, Gosney JR, Giles T, Brambilla C et al.(2009). EUELC project: A multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration. European Respiratory Journal vol. 34, (6) 1477-1486.
10.1183/09031936.00077809
Gillan MGC, Gilbert FJ, Flight H, Cooper J, Wallis MG, James JJ, Boggis CRM, Astley SM et al. (2009). Increasing participant recruitment into large-scale screening trials: experience from the CADET II study. JOURNAL OF MEDICAL SCREENING. vol. 16, 180-185.
10.1258/jms.2009.009023
Pashayan N, Pharoah P, Neal DE, Hamdy F, Donovan J, Martin RM, Greenberg D, Duffy SW(2009). Stage shift in PSA-detected prostate cancers - effect modification by Gleason score. J MED SCREEN vol. 16, (2) 98-101.
10.1258/jms.2009.009037
Brain K, Henderson BJ, Tyndel S, Bankhead C, Watson E, Clements A, Austoker J, Duffy S et al.(2008). Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme. Psycho-Oncology vol. 17, (12) 1180-1188.
10.1002/pon.1355
Gilbert FJ, Astley SM, Gillan MGC, Agbaje OF, Wallis MG, James J, Boggis CRM, Duffy SW et al.(2008). Single reading with computer-aided detection for screening mammography. NEW ENGL J MED vol. 359, (16) 1675-1684.
10.1056/NEJMoa0803545
Duffy SW, Lynge E, Jonsson H, Ayyaz S, Olsen AH(2008). Complexities in the estimation of overdiagnosis in breast cancer screening. Br J Cancer vol. 99, (7) 1176-1178.
10.1038/sj.bjc.6604638
Smith RA, Field JK, Duffy SW(2008). A global approach to cancer-screening trials. LANCET ONCOL vol. 9, (10) 908-909.
10.1016/S1470-2045(08)70211-0
Perry N, Allgood P, Duffy S, Mokbel K(2008). The Impact of Digital Mammography on Screening for Breast Cancer in a Single Specialist Breast Unit. European Journal of Surgical Oncology vol. 34, (10)
10.1016/j.ejso.2008.06.020
Duffy SW, Bowen RL, Ryan DA, Hart IR, Jones JL(2008). Reply: Early onset of breast cancer in black British women: how reliable are the findings?. Br J Cancer
10.1038/sj.bjc.6604626
Field JK, Duffy SW(2008). Lung cancer screening: the way forward. BRIT J CANCER vol. 99, (4) 557-562.
10.1038/sj.bjc.6604509
Ciatto S, Houssami N, Martinelli F, Bonardi R, Cafferty FH, Duffy SW(2008). Second breast cancers in a Tuscan case series: characteristics, prognosis, and predictors of survival. BRIT J CANCER vol. 99, (3) 539-544.
10.1038/sj.bjc.6604481
Duffy SW, Nagtegaal ID, Wallis M, Cafferty FH, Houssami N, Warwick J, Allgood PC, Kearins O et al.(2008). Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol vol. 168, (1) 98-104.
10.1093/aje/kwn120
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL(2008). Reply: Early onset of breast cancer in British black women. British Journal of Cancer vol. 98, (12)
10.1038/sj.bjc.6604416
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL(2008). Early onset of breast cancer in British black women - Reply. BRIT J CANCER vol. 98, (12) 2012-2012.
10.1038/sj.bjc.6604416
Wishart GC, Greenberg DC, Britton PD, Chou P, Brown CH, Purushotham AD, Duffy SW(2008). Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?. BRIT J CANCER vol. 98, (11) 1741-1744.
10.1038/sj.bjc.6604368
Gilbert FJ, Astley SM, Gillan MG, Agbaje OF, Wallis MG, James J, Boggis CR, Duffy SW et al.(2008). CADET II: A prospective trial of computer-aided detection (CAD) in the UK Breast Screening Programme. JOURNAL OF CLINICAL ONCOLOGY vol. 26, (15)
10.1200/jco.2008.26.15_suppl.508
Perry NM, Allgood PC, Duffy SW, Mokbel K(2008). Exposure to traffic emissions throughout life and risk of breast cancer. Cancer Causes and Control vol. 19, (4)
10.1007/s10552-007-9101-x
Bowen R, Duffy S, Ryan D, Hart I, Jones L(2008). Reply: Early onset breast cancer in black British women: a letter to the editor of British Journal of Cancer regarding early onset of breast cancer in a group of British black women. BRIT J CANCER vol. 98, (8) 1483-1484.
10.1038/sj.bjc.6604337
Duffy S, Blamey RW, UKCCCR Breast Cancer Frequency Tri (2008). Long-term mortality results from the UK Breast Screening Frequency Trial. EJC SUPPLEMENTS. vol. 6, 48-48.
10.1016/s1359-6349(08)70316-1
Pal A, Provenzano E, Duffy SW, Pinderl SE, Purushotham AD(2008). A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. BRIT J SURG vol. 95, (3) 302-309.
10.1002/bjs.5943
Perry NM, Allgood PC, Milner SE, Mokbel K, Duffy SW(2008). Mammographic breast density by area of residence: possible evidence of higher density in urban areas. CURR MED RES OPIN vol. 24, (2) 365-368.
10.1185/030079908X260907
Bowen RL, Duffy SW, Ryan DA, Hart IR, Jones JL(2008). Early onset of breast cancer in a group of British black women. Br J Cancer vol. 98, (2) 277-281.
10.1038/sj.bjc.6604174
Cassidy A, Myles JP, van Tongeren M, Page RD, Liloglou T, Duffy SW, Field JK(2008). The LLP risk model: an individual risk prediction model for lung cancer. BRIT J CANCER vol. 98, (2) 270-276.
10.1038/sj.bjc.6604158
Allgood PC, Warwick J, Warren RML, Day NE, Duffy SW(2008). A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer vol. 98, (1) 206-209.
10.1038/sj.bjc.6604123
Duffy SW, Olsen AH, Gabe R, Tabar L, Warwick J, Fielder H, Tryggvadottir L, Agbaje OF(2008). Screening opportunity bias in case-control studies of cancer screening. J APPL STAT vol. 35, (5) 537-546.
10.1080/02664760701835755
Gilbert FJ, Astley SM, Boggis CRM, Mcgee MA, Griffiths PM, Duffy SW, Agbaje OF, Gillan MGC et al.(2008). Variable size computer-aided detection prompts and mammography film reader decisions. BREAST CANCER RES vol. 10, (4) Article R72,
10.1186/bcr2137
Duffy SW, Nagtegaal ID, Astley SM, Gillan MGC, McGee MA, Boggis CRM, Wilson M, Beetles UM et al.(2008). Visually assessed breast density, breast cancer risk and the importance of the craniocaudal view. Breast Cancer Res vol. 10, (4)
10.1186/bcr2123
MacMahon S, Duffy S, Rodgers A, Tominaga S, Chambless L, De Backer G, De Bacquer D, Kornitzer M et al.(2007). Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. The Lancet vol. 370, (9602) 1829-1839.
10.1016/S0140-6736(07)61778-4
Jones JL, Thomas GJ, Duffy SW, Gabe R, Ellis I, Green A, Saha A, Mulligan KT et al. (2007). Expression of alphavbeta6 supersedes Her2 and triple-negative/basal classification of breast cancer and defines novel subgroups with poor survival: implications for breast cancer classification and treatment. BREAST CANCER RESEARCH AND TREATMENT. vol. 106, S11-S11.
Hughes S, Agbaje O, Bowen RL, Holliday DL, Shaw JA, Duffy S, Jones JL(2007). Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression. Clin Cancer Res vol. 13, (22 Pt 1) 6673-6680.
10.1158/1078-0432.CCR-07-0884
Gabe R, Tryggvadóttir L, Sigfússon BF, Olafsdóttir GH, Sigurdsson K, Duffy SW(2007). A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol vol. 48, (9) 948-955.
10.1080/02841850701501725
Gorlov IP, Meyer P, Lilogiou T, Myles J, Boettger MB, Cassidy A, Girard L, Minna JD et al.(2007). Seizure 6-like (SEZ6L) gene and risk for lung cancer. CANCER RES vol. 67, (17) 8406-8411.
10.1158/0008-5472.CAN-06-4784
Field JK, Cassidy A, Miles J, Liloglou T, Xinarianos G, Smith D, Niaz A, Page R et al.(2007). Biomarkers and risk models for stratification of high risk individuals. J THORAC ONCOL vol. 2, (8) S176-S176.
10.1097/01.jto.0000282955.20898.72
Cafferty FH, Wong J-M, Yen AM-F, Duffy SW, Atkin WS, Chen TH-H(2007). Findings at follow-up endoscopies in subjects with suspected colorectal abnormalities: effects of baseline findings and time to follow-up. Cancer J vol. 13, (4) 263-270.
10.1097/PPO.0b013e318046ebf1
Purushotham AD, Britton TMB, Klevesath MB, Chou P, Agbaje OF, Duffy SW(2007). Lymph node status and breast cancer-related lymphedema. Annals of Surgery vol. 246, (1) 42-45.
10.1097/01.sla.0000259390.51203.7b
Duffy SW(2007). Case-Control Studies to Evaluate the Effect of Mammographic Service Screening on Mortality from Breast Cancer. Seminars in Breast Disease vol. 10, (2) 61-63.
10.1053/j.sembd.2007.09.001
Duffy SW, Tabár L, Chen THH, Smith RA, Holmberg L, Jonsson H, Lenner P, Nyström L et al.(2007). Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer vol. 109, (11) 2205-2212.
10.1002/cncr.22671
Duffy SW, Chen THH, Yen AMF, Tabar L, Gabe R, Smith RA(2007). Methodologic Issues in the Evaluation of Service Screening. Seminars in Breast Disease vol. 10, (2) 68-71.
10.1053/j.sembd.2007.09.003
Duffy SW, Jonsson H, Agbaje OF, Pashayan N, Gabe R(2007). Avoiding bias from aggregate measures of exposure. J Epidemiol Community Health vol. 61, (5) 461-463.
10.1136/jech.2006.050203
DUFFY S(2007). Case-control studies of breast cancer screening. Seminars in breast disease
Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK(2007). Lung cancer risk prediction: A tool for early detection. INT J CANCER vol. 120, (1) 1-6.
10.1002/ijc.22331
Cuzick J, Cafferty FH, Edwards R, Møller H, Duffy SW(2007). Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial. J Med Screen vol. 14, (4) 178-185.
10.1258/096914107782912059
Cassidy A, Myles JP, Duffy SW, Liloglou T, Field JK(2006). Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives. BRIT J CANCER vol. 95, (9) 1288-1290.
10.1038/sj.bjc.6603386
Duffy SW, Tabar L, Cherr THH, Yen AMF, Dean PB, Smith RA(2006). What information should be given to women invited for mammographic screening for breast cancer?. Women's Health vol. 2, (6) 829-833.
10.2217/17455057.2.6.829
Gilbert FJ, Astley SM, Mcgee MA, Gillan MGC, Boggis CRM, Griffiths PM, Duffy SW(2006). Single reading with computer-aided detection and double reading of screening mammograms in the United Kingdom national breast screening program. RADIOLOGY vol. 241, (1) 47-53.
10.1148/radiol.2411051092
Pashayan N, Powles J, Brown C, Duffy SW(2006). Erratum: Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia (British Journal of Cancer (2006) 95, (401-405) DOI: 10.1038/sj.bjc.6603246). British Journal of Cancer vol. 95, (5)
10.1038/sj.bjc.6603330
Hughes S, Holliday D, Shaw J, Duffy S, Hart I, Jones L (2006). Analysis of MMP single nucleotide polymorphisms in relation to breast cancer progression. JOURNAL OF PATHOLOGY. vol. 210, 58-58.
Pashayan N, Powles J, Brown C, Duffy SW(2006). Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia. BRIT J CANCER vol. 95, (3) 401-405.
10.1038/sj.bjc.6603246
Pashayan N, Powles J, Brown C, Duffy SW(2006). Incidence trends of prostate cancer in East Anglia, before and during the era of PSA diagnostic testing. BRIT J CANCER vol. 95, (3) 398-400.
10.1038/sj.bjc.6603247
Allgood PC, Duffy SW, Warren R, Hunnam G(2006). Audit of negative assessments in a breast-screening programme in women who later develop breast cancer-implications for survival. Breast vol. 15, (4) 503-509.
10.1016/j.breast.2005.10.002
Buzdar A, Chlebowski R, Cuzick J, Duffy S, Forbes J, Jonat W, Ravdin P, Int Aromatase Inhibitor Expert(2006). Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer. CURR MED RES OPIN vol. 22, (8) 1575-1585.
10.1185/030079906X120940
Olsen AH, Agbaje OF, Myles JP, Lynge E, Duffy SW(2006). Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J vol. 12, (4) 338-342.
10.1111/j.1075-122X.2006.00272.x
Maurice A, Evans DGR, Shenton A, Ashcroft L, Baildam A, Barr L, Byrne G, Bundred N et al.(2006). Screening younger women with a family history of breast cancer - does early detection improve outcome?. EUR J CANCER vol. 42, (10) 1385-1390.
10.1016/j.ejca.2006.01.055
Field JK, Smith RA, Duffy SW, Berg CD, Van Klaveren R, Henschke CI, Carbone D, Postmus PE et al. (2006). The liverpool statement 2005: Priorities for the European Union/United States Spiral Computed Tomography Collaborative Group. Journal of Thoracic Oncology. vol. 1, 497-498.
10.1097/01243894-200606000-00020
Cassidy A, Myles JP, Liloglou T, Duffy SW, Field JK(2006). Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer. INT J ONCOL vol. 28, (5) 1295-1301.
10.3892/ijo.28.5.1295
Smith RA, Caleffi M, Albert US, Chen THH, Duffy SW, Franceschi D, Nystrom L, Global Summit Early Detection Acce(2006). Breast cancer in limited-resource countries: Early detection and access to care. BREAST J vol. 12, (1) S16-S26.
10.1111/j.1075-122X.2006.00200.x
Duffy SW(2006). Cancer screening in Asia. J MED SCREEN vol. 13, S1-S1.
Warwick J, Duffy S, Gabe R (2006). Evaluating the impact of population-based mammography service screening on breast cancer mortality in Western Europe; recent results and methodological challenges. BREAST CANCER RESEARCH AND TREATMENT. vol. 100, S274-S275.
Astley SM, Duffy SW, Boggis CRM, Wilson M, Barr NB, Beetles UM, Griffiths MA, Jain A et al. (2006). Mammography reading with computer-aided detection (CAD): Performance of different readers. DIGITAL MAMMOGRAPHY, PROCEEDINGS. Editors: Astley, SM, Brady, M, Rose, C, Zwiggelaar, R et al., vol. 4046, 97-104.
10.1007/11783237_14
Agbaje OF, Astley SM, Gillan MGC, Boggis CRM, Wilson M, Barr NB, Beetles UM, Griffiths MA et al. (2006). Mammography reading with computer-aided detection (CAD): Single view vs two views. DIGITAL MAMMOGRAPHY, PROCEEDINGS. Editors: Astley, SM, Brady, M, Rose, C, Zwiggelaar, R et al., vol. 4046, 125-130.
10.1007/11783237_18
Duffy SW, Tabar L, Chen THH, Smith RA, Holmberg L, Jonsson H, Lenner P, Nystrom L et al.(2006). Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. CANCER EPIDEM BIOMAR vol. 15, (1) 45-51.
10.1158/1055-9965.EPI-05-0349
Duffy SW, Tabar L, Chen THH, Smith RA, Holmberg L, Jonsson H, Lenner P, Nystrom L et al.(2006). Reduction in breast cancer mortality from the organised service screening with mammography: 2. Validation with alternative analytic methods. CANCER EPIDEM BIOMAR vol. 15, (1) 52-56.
10.1158/1055-9965.EPI-05-0953
Salama I, Mihaimeed F, Marshall J, Jazayeri M, Thomas G, Duffy S, Jones LJ (2006). S100A7 and the basal phenotype in breast cancer. BREAST CANCER RESEARCH AND TREATMENT. vol. 100, S159-S159.
Duffy SW, McCann J, Godward S, Gabe R, Warwick J(2006). Some issues in screening for breast and other cancers. J Med Screen vol. 13 Suppl 1, S28-S34.
Gabe R, Duffy SW, Mackay J, Anderson E, Duffy S, Ellis T, Evans G, Fielder H et al.(2006). The challenge of evaluating annual mammography screening for young women with a family history of breast cancer. J MED SCREEN vol. 13, (4) 177-182.
10.1177/096914130601300404
Duffy SW, Tabar L, Vitak B, Warwick J(2006). Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography?. Breast J vol. 12 Suppl 1, S91-S95.
10.1111/j.1075-122X.2006.00207.x
Duffy SW (2006). Update on the FH01 study. BREAST CANCER RESEARCH. vol. 8, S7-S7.
10.1186/bcr1444
Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Björneld L, Myles JP, Warwick J(2005). Estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Research vol. 7, (6) 258-265.
10.1186/bcr1354
Field JK, Smith DL, Duffy S, Cassidy A(2005). The Liverpool Lung Project research protocol. INT J ONCOL vol. 27, (6) 1633-1645.
Duffy SW, Smith RA, Tabar L(2005). Re: Efficacy of breast cancer screening in the community according to risk level. J NATL CANCER I vol. 97, (22) 1703-1703.
10.1093/jnci/dji379
Duffy SW, Smith RA, Gabe R, Tabár L, Yen AMF, Chen THH(2005). Screening for breast cancer. Surg Oncol Clin N Am vol. 14, (4) 671-697.
10.1016/j.soc.2005.06.001
Field J, Xinarianos G, Myles J, Nikolaidis G, Cassidy A, Duffy S, Liloglou T (2005). Lung cancer susceptibility: A CDKN1A promoter polymorphism enhances the risk for lung cancer. LUNG CANCER. vol. 49, S82-S82.
DUFFY SW, Myles JP, Myles J, Hollingworth W, Bobrow L, Miller K, Klevesath M, Upponi S et al.(2005). Morbidity after sentinel lymph node biopsy in primary breast cancer - results from a randomised controlled trial. J Clin Oncol vol. 23, 4312-4321.
10.1200/JCO.2005.03.228
Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW(2005). Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol vol. 23, (19) 4312-4321.
10.1200/JCO.2005.03.228
Tyrer J, Duffy SW, Cuzick J, de Bock GH, Jacobi CE, Jonker MA, Nagelkerke NJD, van Houwelingen JC(2005). A breast cancer prediction model (multiple letters) [2]. Statistics in Medicine vol. 24, (10) 1610-1612.
10.1002/sim.2013
Cuzick J, Duffy S, Tyrer J(2005). A breast cancer prediction model - Authors' reply. STAT MED vol. 24, (10) 1612-1612.
10.1002/sim.2014
Duffy SW(2005). Commentary: Axillary dissection in breast cancer updated. BREAST vol. 14, (2) 83-84.
10.1016/j.breast.2004.09.007
Klevesath MB, Pantel K, Duffy SW, Gough P, Bobrow L, Purushotham AD (2005). Metastatic pathways in early breast cancer. BRITISH JOURNAL OF SURGERY. vol. 92, 65-65.
Duffy SW, Gabe R(2005). What should the detection rates of cancers be in breast screening programmes?. Br J Cancer vol. 92, (3) 597-600.
10.1038/sj.bjc.6602345
Duffy SW(2005). Lymph node status in screen-detected cancers. BRIT J CANCER vol. 92, (1) 3-4.
10.1038/sj.bjc.6602290
Tyrer J, Duffy SW, Cuzick J(2005). A breast cancer prediction model incorporating familial and personal risk factors (vol 23, pg 1111, 2004). STAT MED vol. 24, (1) 156-156.
10.1002/sim.1913
Warwick J, Duffy SW(2005). A review of cancer screening evaluation techniques, with some particular examples in breast cancer screening. J ROY STAT SOC A STA vol. 168, 657-677.
10.1111/j.1467-985X.2005.00371.x
Gabe R, Duffy SW(2005). Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncol vol. 16 Suppl 2, ii153-ii162.
10.1093/annonc/mdi718
Warwick J, Fielder H, Duffy S(2005). Mammographic screening only matters in the detectable preclinical period of breast cancer - Author response. J MED SCREEN vol. 12, (2) 107-107.
10.1258/0969141053908267
Paci E, Duffy S(2005). Overdiagnosis and overtreatment of breast cancer - Overdiagnosis and overtreatment in service screening. BREAST CANCER RES vol. 7, (6) 266-270.
10.1186/bcr1339
Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Björneld L, Myles JP, Warwick J(2005). Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res vol. 7, (6) 258-265.
10.1186/bcr1354
Duffy SW(2005). Some current issues in breast cancer screening. J Med Screen vol. 12, (3) 128-133.
10.1258/0969141054855319
Tabar L, Chen HHT, Yen MFA, Tot T, Tung TH, Chen LS, Chiu YH, Duffy SW et al.(2004). Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma - Suggestions for the reconsideration of current therapeutic practice and the TNM classification system. CANCER vol. 101, (8) 1745-1759.
10.1002/cncr.20582
Peacock C, Given-Wilson R, Duffy S(2004). Mammographic casting-type calcification associated with small screen-detected invasive breast cancers: Is this a reliable prognostic indicator? [2]. Clinical Radiology vol. 59, (9)
10.1016/j.crad.2004.06.009
Smith RA, Duffy SW, Gabe R, Tabar L, Yen AMF, Chen THH(2004). The randomized trials of breast cancer screening: what have we learned?. RADIOL CLIN N AM vol. 42, (5) 793-+.
10.1016/j.rcl.2004.06.014
Duffy SW, Warwick J, Williams ARW, Keshavarz H, Kaffashian F, Rohan TE, Nili F, Sadeghi-Hassanabadi A(2004). A simple model for potential use with a misclassified binary outcome in epidemiology. J Epidemiol Community Health vol. 58, (8) 712-717.
10.1136/jech.2003.010546
Duffy SW, Jakes RW, Ng FC, Gao F(2004). Interaction of dense breast patterns with other breast cancer risk factors in a case-control study. Br J Cancer vol. 91, (2) 233-236.
10.1038/sj.bjc.6601911
Fielder H, Brook D, Cuzick J, Warwick J, Duffy S(2004). A case–control study to estimate the impact on breast cancer death of the breast screening programme in Wales. Breast Cancer Research vol. 6, (Suppl 1)
10.1186/bcr827
Gabe R, Duffy S(2004). The impact of mammographic screening on breast cancer mortality: overview of the evidence so far. Breast Cancer Research vol. 6, (Suppl 1)
10.1186/bcr826
Tabar L, Yen MF, Vitak B, Chen NN, Smith RA, Duffy SW(2004). Mammography service screening and mortality. BIOMED PHARMACOTHER vol. 58, (4) 269-270.
10.1016/j.biopha.2004.03.002
Wong JM, Yen MF, Lai MS, Duffy SW, Smith RA, Chen THH(2004). Progression rates of colorectal cancer by Dukes' stage in a high-risk group: Analysis of selective colorectal cancer screening. CANCER J vol. 10, (3) 160-169.
10.1097/00130404-200405000-00005
Cuzick J, Warwick J, Pinney E, Warren RML, Duffy SW(2004). Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst vol. 96, (8) 621-628.
10.1093/jnci/djh106
Tyrer J, Duffy SW, Cuzick J(2004). A breast cancer prediction model incorporating familial and personal risk factors. Stat Med vol. 23, (7) 1111-1130.
10.1002/sim.1668
Warwick J, Tabàr L, Vitak B, Duffy SW(2004). Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study. Cancer vol. 100, (7) 1331-1336.
10.1002/cncr.20140
Paci E, Duffy S, Falini R, Warvick J(2004). An estimate of the overdiagnosis in service screening: an evaluation in the Florence City Program. EJC SUPPL vol. 2, (3) 89-89.
10.1016/s1359-6349(04)90722-7
Duffy SW, Tabar L, Smith RA(2004). Reply to comment on "The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease" by A.C. Voogd, M.F. Ernst. EUR J CANCER vol. 40, (5) 776-777.
10.1016/j.ejca.2003.11.017
Peacock C, Given-Wilson RM, Duffy SW(2004). Mammographic casting-type calcification associated with small screen-detected invasive breast cancers: is this a reliable prognostic indicator?. CLIN RADIOL vol. 59, (2) 165-170.
10.1016/j.crad.2003.07.006
Myles JP, Salmininen T, Duffy SW, Prevost TC, Day NE, Hakama M(2004). Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement therapy. Breast vol. 13, (1) 56-60.
10.1016/j.breast.2003.10.007
Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I, Duffy SW(2004). A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J MED SCREEN vol. 11, (4) 194-198.
10.1258/0969141042467304
Warren R, Allgood P, Hunnam G, Godward S, Duffy S, E Anglian Breast Screening Program(2004). An audit of assessment procedures in women who develop breast cancer after a negative result. J MED SCREEN vol. 11, (4) 180-186.
10.1258/0969141042467395
Voogd AC, Ernst MF, Duffy SW, Tabar L, Smith RA(2004). Comment on "the relative contributions of screen-detected in-situ and invasive breast carcinomas in reducing mortality from the disease" by S.W. Duffy, L. Tabar, B. Vitak et al. [1] (multiple letters). European Journal of Cancer vol. 40, (5) 774-775.
10.1016/j.ejca.2003.11.018
Cuzick J, DUFFY SW, Warren RML, Pinney E, Warwick J(2004). Effect of tamoxifen on women at increased risk of breast cancer. J Natl. Cancer Institute. vol. 96, 621-628.
DUFFY SW, Warwick J, Vitak B, Tabar L(2004). Long-term survival with breast cancer: evidence from the Swedish Two-County study (1977-98). Am J Oncol Rev. vol. 3, 376-385.
McCann J, Treasure P, Duffy S(2004). Modelling the impact of detecting and treating carcinoma in situ in a breast screening programme. J MED SCREEN vol. 11, (3) 117-125.
10.1258/0969141041732201
Tabar L, Vitak B, Yen MFA, Chen HHT, Smith RA, Duffy SW(2004). Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. J MED SCREEN vol. 11, (3) 126-129.
10.1258/0969141041732175
Paci E, Warwick J, Falini P, Duffy SW(2004). Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?. J MED SCREEN vol. 11, (1) 23-27.
10.1177/096914130301100106
Duffy S, Jackson TL, Lansdown M, Philips K, Wells M, Pollard S, Clack G, Cuzick J et al.(2003). The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data. BJOG vol. 110, (12) 1099-1106.
10.1111/j.1471-0528.2003.02120.x
Kaffashian F, Godward S, Davies T, Solomon L, McCann J, Duffy SW(2003). Socioeconomic effects on breast cancer survival: proportion attributable to stage and morphology. BRIT J CANCER vol. 89, (9) 1693-1696.
10.1038/sj.bjc.6601339
Nixon RM, Duffy SW, Fender GRK(2003). Imputation of a true endpoint from a surrogate: Application to a cluster randomized controlled trial with partial information on the true endpoint. BMC Medical Research Methodology vol. 3, 1-11.
10.1186/1471-2288-3-17
Nixon RM, Duffy SW, Fender GRK(2003). Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint. BMC Med Res Methodol vol. 3,
10.1186/1471-2288-3-17
Liu WJ, Lee LT, Yen MF, Tung TH, Williams R, Duffy SW, Chen THH(2003). Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan. DIABETIC MED vol. 20, (9) 727-733.
10.1046/j.1464-5491.2003.01019.x
Duffy SW, Rohan TE, Kandel R, Prevost TC, Rice K, Myles JP(2003). Misclassification in a matched case-control study with variable matching ratio: application to a study of c-erbB-2 overexpression and breast cancer. Stat Med vol. 22, (15) 2459-2468.
10.1002/sim.1477
Myles JP, Price GM, Hunter N, Day M, Duffy SW(2003). A potentially useful distribution model for dietary intake data. Public Health Nutr vol. 6, (5) 513-519.
10.1079/PHN2003459
Yen M-F, Tabár L, Vitak B, Smith RA, Chen H-H, Duffy SW(2003). Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer vol. 39, (12) 1746-1754.
10.1016/s0959-8049(03)00260-0
Duffy SW, Tabar L, Vitak B, Yen MF, Warwick J, Smith RA, Chen HH(2003). The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation. Ann Oncol vol. 14, (8) 1196-1198.
10.1093/annonc/mdg322
Duffy SW, Tabar L, Vitak B, Day NE, Smith RA, Chen HHT, Yen MFA(2003). The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer vol. 39, (12) 1755-1760.
10.1016/s0959-8049(03)00259-4
Tabar L, Duffy SW, Smith RA(2003). Mammography service screening and mortality - Reply. LANCET vol. 362, (9380) 330-330.
10.1016/s0140-6736(03)13983-9
Gøtzsche PC, Tabar L, Duffy SW, Smith RA(2003). Mammography service screening and mortality [4] (multiple letters). Lancet vol. 362, (9380) 329-330.
10.1016/S0140-6736(03)13982-7
Myles JP, Nixon RM, Duffy SW, Tabar L, Boggis C, Evans G, Shenton A, Howell A(2003). Bayesian evaluation of breast cancer screening using data from two studies. STAT MED vol. 22, (10) 1661-1674.
10.1002/sim.1365
Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, Walker N, Cahlin E et al.(2003). The Gothenburg Breast Screening Trial. CANCER vol. 97, (10) 2387-2396.
10.1002/cncr.11361
Tabar L, Yen MF, Vitak B, Chen HHT, Smith RA, Duffy SW(2003). Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. LANCET vol. 361, (9367) 1405-1410.
10.1016/S0140-6736(03)13143-1
Jakes RW, Duffy SW(2003). Correspondence re: Jakes et al., mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiol Biomark. Prev., 11 : 608-613, 2002 - Reply. CANCER EPIDEM BIOMAR vol. 12, (4) 387-387.
Warwick J, Pinney E, Warren RML, Duffy SW, Howell A, Wilson M, Cuzick J(2003). Breast density and breast cancer risk factors in a high-risk population. Breast vol. 12, (1) 10-16.
10.1016/s0960-9776(02)00212-6
Warren RML, Young JR, McLean L, Lyons K, Wilson ARM, Evans A, Duffy SW, Warsi IM(2003). Radiology review of the UKCCCR breast screening frequency trial: Potential improvements in sensitivity and lead time of radiological signs. CLIN RADIOL vol. 58, (2) 128-132.
10.1053/crad.2002.1132
DUFFY SW, Sala E, Bjorneld L, Warwick J, Bjurstam N(2003). Age-specific effects of beast cancer screening: the randomized breast screening trial in Gothenburg. Amer. J. Oncol. Rev. vol. 2, 435-442.
Miller AB, To T, Baines CJ, Wall C, Duffy SW(2003). Annual mammography and breast examination did not reduce breast cancer mortality in women aged 40-49 years. Evidence-based Obstetrics and Gynecology vol. 5, (1) 46-47.
10.1016/S1361-259X(03)00006-0
DUFFY SW, Patel DD, Bala DV(2003). Breast cancer, reported dietary intakes and dietary biomarkers: a case-control study in Gujarat, India. Res. Adv. Cancer vol. 3, 219-230.
DUFFY SW(2003). Commentary on CNBSS-1. Evidence Based Obstet Gynaecol vol. 5,
Tabar L, Smith RA, Vitak B, Yen MF, Chen THH, Warwick J, Myles JP, Duffy SW(2003). Mammographic screening: A key factor in the control of breast cancer. CANCER J vol. 9, (1) 15-27.
10.1097/00130404-200301000-00004
Jackson CH, Sharples LD, Thompson SG, Duffy SW, Couto E(2003). Multistate Markov models for disease progression with classification error. J ROY STAT SOC D-STA vol. 52, 193-209.
10.1111/1467-9884.00351
Nixon RM, Duffy SW(2002). Cross-issue synthesis: Potential application to breast cancer, tamoxifen and genetic susceptibility. Journal of Cancer Epidemiology and Prevention vol. 7, (4) 205-212.
Duffy SW(2002). The controversy over breast cancer screening. HOSP MED vol. 63, (12) 708-709.
10.12968/hosp.2002.63.12.1889
Smith R, Duffy S, Tabar L(2002). The mammographic screening trials: Commentary on the recent work by Olsen and Gotzsche (Reprinted from A Cancer Journal for Clinicians, vol 52, pg 68-71, 2002) - Reply. J SURG ONCOL vol. 81, (4) 164-166.
10.1002/jso.10196
Beral V, Hamajima N, Hirose K, Rohan T, Calle EE, Heath CW, Coates RJ, Liff JM et al.(2002). Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease. BRIT J CANCER vol. 87, (11) 1234-1245.
10.1038/sj.bjc.6600596
Multicentre Aneurysm Screening Study Group(2002). Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial. BMJ vol. 325, (7373)
10.1136/bmj.325.7373.1135
Harrison DA, Duffy SW, Sala E, Warren RML, Couto E, Day NE(2002). Deterministic models for breast cancer progression: Application to the association between mammographic parenchymal pattern and histologic grade of breast cancers. J CLIN EPIDEMIOL vol. 55, (11) 1113-1118.
10.1016/s0895-4356(02)00483-3
Liao CS, Yang KC, Yen MF, Teng LL, Duffy SW, Chen THH(2002). Prognosis of small hepatocellular carcinoma treated by percutaneous ethanol injection and transcatheter arterial chemoembolization. Journal of Clinical Epidemiology vol. 55, (11) 1095-1104.
10.1016/S0895-4356(02)00487-0
Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Vezzosi V, Bianchi S, Cataliotti L et al.(2002). Are breast cancer screening programmes increasing rates of mastectomy? Observational study. British Medical Journal vol. 325, (7361)
10.1136/bmj.325.7361.418
Duffy SW, Tabar L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E et al.(2002). The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties - A collaborative evaluation. CANCER vol. 95, (3) 458-469.
10.1002/cncr.10765
Tabar L, Smith RA, Duffy SW(2002). Update on effects of screening mammography. LANCET vol. 360, (9329) 337-337.
10.1016/S0140-6736(02)09523-5
Tabár L, Smith RA, Duffy SW, Bonneux L, Gøtzsche PC, Cheng KK, Gulbrandsen P, Nyström L et al.(2002). Update on effects of screening mammography [1] (multiple letters). Lancet vol. 360, (9329) 337-340.
10.1016/S0140-6736(02)09523-5
Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH, Seow A, Lee HP, Yu MC(2002). Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. CANCER EPIDEM BIOMAR vol. 11, (7) 608-613.
Chen THH, Chen CJ, Yen MF, Lu SN, Sun CA, Huang GT, Yang PM, Lee HS et al.(2002). Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. International Journal of Cancer vol. 98, (2) 257-261.
10.1002/ijc.10122
Duffy SW, Tabar L, Smith RA(2002). The mammographic screening trials: Commentary on the recent work by Olsen and Gotzsche. CA-CANCER J CLIN vol. 52, (2) 68-71.
10.3322/canjclin.52.2.68
Gøtzsche PC, Olsen O, Ponzone R, Sismondi P, Baum M, Kopans DB, Tabár L, Duffy S et al.(2002). Beyond randomized controlled trials: Organized mammographic screening substantially reduces breast carcinoma mortality [2] (multiple letters). Cancer vol. 94, (2)
10.1002/cncr.10224
Tabar L, Duffy SW, Yen MF, Warwick J, Vitak B, Chen HH, Smith RA(2002). All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. J MED SCREEN vol. 9, (4) 159-162.
10.1136/jms.9.4.159
Duffy SW, Cuzick J, Tabar L, Vitak B, Chen THH, Yen MF, Smith RA(2002). Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. J ROY STAT SOC C-APP vol. 51, 235-243.
10.1111/1467-9876.00266
Duffy SW, Nixon RM(2002). Estimates of the likely prophylactic effect of tamoxifen in women with high risk BRCA1 and BRCA2 mutations. British Journal of Cancer vol. 86, (2) 218-221.
10.1038/sj.bjc.6600064
Myles JP, Duffy SW, Prevost TC, Day NE, Hakama M, Salminen T(2002). Markov chain Monte Carlo inference applied to a complex model for the longitudinal analysis of breast patterns. J ROY STAT SOC C-APP vol. 51, 197-207.
10.1111/1467-9876.00263
Couto E, Duffy SW, Ashton HA, Walker NM, Myles JP, Scott RAP, Thompson SG(2002). Probabilities of progression of aortic aneurysms: estimates and implications for screening policy. J MED SCREEN vol. 9, (1) 40-42.
10.1136/jms.9.1.40
Paci E, Duffy SW, Giorgi D, Zappa M, Crocetti E, Vezzosi V, Bianchi S, Rosselli del Turco M(2002). Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. British Journal of Cancer vol. 87, (1) 65-69.
10.1038/sj.bjc.6600301
Blamey RW, Day NE, Young JR, Ellis IO, Pinder SE, Duffy SW, Lyons K, Monypenny I et al.(2002). The frequency of breast cancer screening: Results from the UKCCCR Randomised Trial. European Journal of Cancer vol. 38, (11) 1458-1464.
10.1016/S0959-8049(01)00397-5
Duffy S, Tabár L, Smith RA(2002). The mammographic screening trials: commentary on the recent work by Olsen and Gøtzsche. Journal of surgical oncology vol. 81, (4)
10.1002/jso.10193
Mackay J, Rogers C, Fielder H, Blamey R, Macmillan D, Boggis C, Brown J, Pharoah PD et al.(2001). Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer. Journal of Epidemiology and Biostatistics vol. 6, (5) 365-369.
10.1080/135952201753337086
Couto E, Harrison DAH, Duffy SW, Myles J, Sala E, Warren RML, Day NE, Luben R et al.(2001). Estimation of disease progression parameters from case-control data: Application to mammographic patterns and breast cancer natural history. Journal of Epidemiology and Biostatistics vol. 6, (2) 235-242.
10.1080/135952201753173015
Schlecht NF, Franco EL, Rohan TE, Kjaer SK, Schiffman MH, Moscicki AB, Duffy SW, Svare EI et al.(2001). Repeatability of sexual history in longitudinal studies on HPV infection and cervical neoplasia: Determinants of reporting error at follow-up interviews. Journal of Epidemiology and Biostatistics vol. 6, (5) 393-407.
10.1080/135952201753337149
Mackay J, Duffy SW(2001). Reply. Journal of Epidemiology and Biostatistics vol. 6, (5)
10.1080/135952201753337031
Miller AB, Lee JH, Zuckerman D, Senn S, Thornton H, Duffy SW, Tabar L, Smith RA et al.(2001). Screening for breast cancer with mammography [1] (multiple letters). Lancet vol. 358, (9299) 2164-2168.
10.1016/S0140-6736(01)07189-6
Myles J, Duffy S, Nixon R, Boggis C, Howell A, Shenton A, Evans G(2001). Initial results of a study into the effectiveness of breast cancer screening in a population identified to be at high risk. Revue d'Epidemiologie et de Sante Publique vol. 49, (5) 471-475.
Duffy SW, Cuzick J(2001). Let's talk about mammographic screening over again - response. BREAST vol. 10, (5) 450-451.
Keshavarz H, Duffy SW, Sadeghi-Hassanabadi A, Zolghadr Z, Oboodi B(2001). Risk factors for and relationship between bacterial vaginosis and cervicitis in a high risk population for cervicitis in Southern Iran. European Journal of Epidemiology vol. 17, (1) 89-95.
10.1023/A:1010935723248
Sala E, Warren R, McCann J, Duffy S, Luben R, Day N(2001). Mammographic parenchymal patterns and breast cancer natural history: A case-control study. Acta Oncologica vol. 40, (4) 461-465.
10.1080/028418601750288172
Nixon RM, Duffy SW, Fender GRK, Day NE, Prevost TC(2001). Randomization at the level of primary care practice: Use of pre-intervention data and random effects models. Statistics in Medicine vol. 20, (12) 1727-1738.
10.1002/sim.792
Tabár L, Vitak B, Tonychen HH, Yen MF, Duffy SW, Smith RA(2001). Beyond randomized controlled trials: Organized mammographic screening substantially reduces breast carcinoma mortality. Cancer vol. 91, (9) 1724-1731.
10.1002/1097-0142(20010501)91:9<1724::AID-CNCR1190>3.0.CO;2-V
Fender GRK, Prentice A, Nixon RM, Gorst T, Duffy SW, Day NE, Smith SK(2001). Management of menorrhagia: An audit of practices in the Anglia menorrhagia education study. British Medical Journal vol. 322, (7285) 523-524.
10.1136/bmj.322.7285.523
McCann J, Duffy S, Day N(2001). Predicted long-term mortality reduction associated with the second round of breast screening in East Anglia. British Journal of Cancer vol. 84, (3) 423-428.
10.1054/bjoc.2000.1609
Jakes RW, Alexander L, Duffy SW, Leong J, Chen LH, Lee WH(2001). Dietary intake of soybean protein and menstrual cycle length in pre-menopausal Singapore Chinese women. Public Health Nutrition vol. 4, (2) 191-196.
10.1079/phn200063
Duffy SW(2001). Interpretation of the breast screening trials: A commentary on the recent paper by Gøtzsche and Olsen. Breast vol. 10, (3) 209-212.
10.1054/brst.2000.0238
De Nigris A, Paladini G, Duffy SW, Cuzick J(2001). Letter to the editor (multiple lettes) [1]. Breast vol. 10, (5) 450-451.
Bala DV, Patel DD, Duffy SW, Cherman S, Patel PS, Trivedi J, Pinaki P, Pandey P et al.(2001). Role of dietary intake and biomarkers in risk of breast cancer: A case control study. Asian Pacific Journal of Cancer Prevention vol. 2, (2) 123-130.
Duffy SW, Tabar L, Smith RA(2001). Screening for breast cancer with mammography. Lancet vol. 358, (9299)
10.1016/S0140-6736(01)07194-X
Scott RAP, Vardulaki KA, Walker NM, Day NE, Duffy SW, Ashton HA(2001). The long-term benefits of a single scan for abdominal aortic aneurysm (AAA) at age 65. European Journal of Vascular and Endovascular Surgery vol. 21, (6) 535-540.
10.1053/ejvs.2001.1368
Sala E, Warren R, McCann J, Duffy S, Luben R, Day N(2000). Smoking and high-risk mammographic parenchymal patterns: A case-control study. Breast Cancer Research vol. 2, (1) 59-63.
10.1186/bcr29
Nixon RM, Pharoah P, Tabar L, Krusemo UB, Duffy SW, Prevost TC, Chen HH(2000). Mammographic screening in women with a family history of breast cancer: Some results from the Swedish two-county trial. Revue d'Epidemiologie et de Sante Publique vol. 48, (4) 325-331.
Park PJ, Griffin SJ, Duffy SW, Wareham NJ(2000). The effect of varying the screening interval on false positives and duration of undiagnosed disease in a screening programme for type 2 diabetes. Journal of Medical Screening vol. 7, (2) 91-96.
10.1136/jms.7.2.91
Chappuls PO, Deschenes J, Foulkes WD, Atkins CD, Blamey RW, Spratt JS, Tabar L, Duffy SW et al.(2000). Long-term outcome of invasive breast cancer (multiple letters). Lancet vol. 355, (9214) 1551-1553.
10.1016/S0140-6736(00)02178-4
Miller AB, Baines CJ, To T, Wall C, Duffy SW, Tabar L, Moss S, Blanks R et al.(2000). Screening mammography re-evaluated (multiple letters). Lancet vol. 355, (9205) 747-752.
10.1016/S0140-6736(00)00031-3
Duffy SW, Tabar L(2000). Screening mammography re-evaluated. Lancet vol. 355, (9205) 747-752.
10.1016/S0140-6736(05)72152-8
Vardulaki KA, Walker NM, Day NE, Duffy SW, Ashton HA, Scott RAP(2000). Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. British Journal of Surgery vol. 87, (2) 195-200.
10.1046/j.1365-2168.2000.01353.x
Tabár L, Chen HH, Duffy SW, Yen MF, Chiang CF, Dean PB, Smith RA(2000). A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: A prospective study. Lancet vol. 355, (9202) 429-433.
10.1016/S0140-6736(00)82008-5
Tabar L, Dean PB, Kaufman CS, Duffy SW, Chen HH(2000). A new era in the diagnosis of breast cancer. Surgical Oncology Clinics of North America vol. 9, (2) 233-277.
10.1016/s1055-3207(18)30153-4
Chen THH, Kuo HS, Yen MF, Lai MS, Tabar L, Duffy SW(2000). Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics vol. 56, (1) 167-172.
10.1111/j.0006-341X.2000.00167.x
Sala E, Warren R, Duffy S, Welch A, Luben R, Day N(2000). High risk mammographic parenchymal patterns and diet: A case-control study. British Journal of Cancer vol. 83, (1) 121-126.
10.1054/bjoc.2000.1151
Sala E, Warren R, McCann J, Duffy S, Luben R, Day N(2000). High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: A case-control study. International Journal of Epidemiology vol. 29, (4) 629-636.
10.1093/ije/29.4.629
Warren R, Duffy S(2000). Interval cancers as an indicator of perfomance in breast screening. Breast Cancer vol. 7, (1) 9-18.
10.1007/BF02967182
Jakes RW, Duffy SW, Ng FC, Gao F, Ng EH(2000). Mammographic parenchymal patterns and risk of breast cancer at and after a prevalence screen in Singaporean women. International Journal of Epidemiology vol. 29, (1) 11-19.
10.1093/ije/29.1.11
Sala E, Solomon L, Warren R, McCann J, Duffy S, Luben R, Day N(2000). Size, node status and grade of breast tumours: Association with mammographic parenchymal patterns. European Radiology vol. 10, (1) 157-161.
10.1007/s003300050025
Nixon R, Prevost TC, Duffy SW, Tabar L, Vitak B, Chen HH(2000). Some random-effects models for the analysis of matched-cluster randomised trials: application to the Swedish two-county trial of breast-cancer screening. Journal of epidemiology and biostatistics vol. 5, (6) 349-358.
Tabár L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF, Krusemo UB, Tot T et al.(2000). The Swedish two-county trial twenty years later: Updated mortality results and new insights from long-term follow-up. Radiologic Clinics of North America vol. 38, (4) 625-651.
10.1016/S0033-8389(05)70191-3
Andrieu N, Prevost T, Rohan TE, Luporsi E, Lê MG, Gerber M, Zaridze DG, Lifanova Y et al.(2000). Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality. International Journal of Epidemiology vol. 29, (2) 214-223.
10.1093/ije/29.2.214
Iso H, Sato H, Chambless L, De Backer G, De Bacquer D, Kornitzer M, Ebrahim S, Whincup P et al.(1999). Collaborative overview ('meta-analysis') of prospective observational studies of the associations of usual blood pressure and usual cholesterol levels with common causes of death: Protocol for the second cycle of the Prospective Studies Collaboration. Journal of Cardiovascular Risk vol. 6, (5) 315-320.
10.1177/204748739900600508
Tabar L, Duffy SW(1999). Criticisms of Swedish mammography trials were wrong [3]. British Medical Journal vol. 319, (7221)
10.1136/bmj.319.7221.1367
Wong MY, Day NE, Bashir SA, Duffy SW(1999). Measurement error in epidemiology: The design of validation studies I: Univariate situation. Statistics in Medicine vol. 18, (21) 2815-2829.
10.1002/(sici)1097-0258(19991115)18:21<2815::aid-sim280>3.0.co;2-%23
Chen THH, Yen MF, Lai MS, Koong SL, Wang CY, Wong JM, Prevost TC, Duffy SW(1999). Evaluation of a selective screening for colorectal carcinoma: The Taiwan Multicenter Cancer Screening (TAMCAS) project. Cancer vol. 86, (7) 1116-1128.
10.1002/(SICI)1097-0142(19991001)86:7<1116::AID-CNCR4>3.0.CO;2-D
Tabár L, Duffy SW, Vitak B, Chen HH, Prevost TC(1999). The natural history of breast carcinoma: What have we learned from screening?. Cancer vol. 86, (3) 449-462.
10.1002/(SICI)1097-0142(19990801)86:3<449::AID-CNCR13>3.0.CO;2-Q
Grant C, Gray A, Paoletti R, Thornton H, Von Kleist S, Beral V, Burger H, Creasman W et al. (1999). Hormone Replacement Therapy conference, European Institute of Oncology, Milan, Italy, 23-25 June 1999: Hormone replacement therapy. Lancet. vol. 354, 152-155.
10.1016/S0140-6736(99)06570-8
Fender GRK, Prentice A, Gorst T, Nixon RM, Duffy SW, Day NE, Smith SK(1999). Randomised controlled trial of educational package on management of menorrhagia in primary care: The Anglia menorrhagia education study. British Medical Journal vol. 318, (7193) 1246-1250.
10.1136/bmj.318.7193.1246
Chen HH, Prevost TC, Duffy SW(1999). Evaluation of screening for nasopharyngeal carcinoma: Trial design using Markov chain models. British Journal of Cancer vol. 79, (11-12) 1894-1900.
10.1038/sj.bjc.6690301
Sala E, Warren R, McCann J, Duffy S, Luben R, Day N(1999). High risk mammographic parenchymal patterns and anthropometric measures: A case-control study. British Journal of Cancer vol. 81, (7) 1257-1261.
10.1038/sj.bjc.6690838
Prevost TC, Rohan TE, Duffy SW, Chen HH, To T, Hill RD(1999). Markov chain models and estimation of absolute progression rates: application to cataract progression in diabetic adults. Journal of epidemiology and biostatistics vol. 4, (4) 337-344.
Duffy SW, Keshavarz H, Sadeghi-Hassanabadi A, Zolghadr Z, Oboodi B(1999). Prevalence of cervicitis in women living in southern Iran. Revue d'Epidemiologie et de Sante Publique vol. 47, (1)
Tabar L, Chen HHT, Duffy SW, Krusemo UB(1999). Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening. Japanese Journal of Clinical Oncology vol. 29, (12) 608-616.
10.1093/jjco/29.12.608
Tabar L, Vitak B, Chen HH, Prevost TC, Duffy SW(1999). Update of the Swedish two-county trial of breast cancer screening: Histologic grade-specific and age-specific results. Swiss Surgery vol. 5, (5) 199-204.
10.1024/1023-9332.5.5.199
Prevost TC, Spiegelhalter DJ, Duffy SW(1999). Use of person-years of CIN III exposure as a surrogate outcome measure in cervical cancer screening trials. Journal of epidemiology and biostatistics vol. 4, (1) 19-29.
Tabár L, Duffy SW, Chen HH (1998). Where now? The future of imaging of breast diseases. Imaging. vol. 10,
Launoy G, Duffy SW, Prevost TC, Bouvier V(1998). Test sensitivity and program sensitivity for cancer screening. Revue d'Epidemiologie et de Sante Publique vol. 46, (5) 420-426.
Prevost TC, Launoy G, Duffy SW, Chen HH(1998). Estimating Sensitivity and Sojourn Time in Screening for Colorectal Cancer: A Comparison of Statistical Approaches. American Journal of Epidemiology vol. 148, (6) 609-619.
10.1093/oxfordjournals.aje.a009687
Lai MS, Yen MF, Kuo HS, Koong SL, Chen THH, Duffy SW(1998). Efficacy of breast-cancer screening for female relatives of breast- cancer-index cases: Taiwan multicentre cancer screening (TAMCAS). International Journal of Cancer vol. 78, (1) 21-26.
10.1002/(SICI)1097-0215(19980925)78:1<21::AID-IJC5>3.0.CO;2-Z
Miller AB, Baines CJ, To T, Bjurstam N, Bjorneld L, Duffy SW, Prevost TC(1998). The Gothenburg breast screening trial: First results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization (multiple letters). Cancer vol. 83, (1) 186-188.
10.1002/(SICI)1097-0142(19980701)83:1<186::AID-CNCR25>3.0.CO;2-S
Seow A, Duffy SW, Ng TP, McGee MA, Lee HP(1998). Lung cancer among Chinese females in Singapore 1968-1992: Time trends, dialect group differences and implications for aetiology. International Journal of Epidemiology vol. 27, (2) 167-172.
10.1093/ije/27.2.167
Chen HH, Thurfjell E, Duffy SW, Tabar L(1998). Evaluation by Markov chain models of a non-randomised breast cancer screening programme in women aged under 50 years in Sweden. Journal of Epidemiology and Community Health vol. 52, (5) 329-335.
10.1136/jech.52.5.329
Sala E, Warren R, McCann J, Duffy S, Day N, Luben R(1998). Mammographic parenchymal patterns and mode of detection: Implications for the breast screening programme. Journal of Medical Screening vol. 5, (4) 207-212.
10.1136/jms.5.4.207
Launoy G, Duffy SW, Prevost TC, Bouvier V(1998). Re: Fecal occult blood screening in the Minnesota study. Journal of the National Cancer Institute vol. 90, (6) 465-467.
10.1093/jnci/90.6.465-a
Andrieu N, Smith T, Duffy S, Zaridze DG, Renaud R, Rohan T, Gerber M, Luporsi E et al.(1998). The effects of interaction between familial and reproductive factors on breast cancer risk: A combined analysis of seven case-control studies. British Journal of Cancer vol. 77, (9) 1525-1536.
10.1038/bjc.1998.251
Bjurstam N, Björneld L, Duffy SW, Smith TC, Cahlin E, Eriksson O, Hafström LO, Lingaas H et al.(1997). The Gothenburg breast screening trial: First results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer vol. 80, (11) 2091-2099.
10.1002/(sici)1097-0142(19971201)80:11<2091::aid-cncr8>3.0.co;2-%23
Calle EE, Heath CW, Coates RJ, Liff JM, Franceschi S, Talamini R, Chantarakul N, Koetsawang S et al.(1997). Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet vol. 350, (9084) 1047-1059.
10.1016/S0140-6736(97)08233-0
Keshavarz H, Duffy SW, Sotodeh-Maram E, Saraf Z, Sadeghi-Hassana-Badi A, Zighami B, Tabei Z(1997). Factors related to cervicitis in Qashghaee nomadic women of southern Iran. Revue d'Epidemiologie et de Sante Publique vol. 45, (4) 279-285.
Pharoah PDP, Day NE, Duffy S, Easton DF, Ponder BAJ(1997). Family history and the risk of breast cancer: A systematic review and meta-analysis. International Journal of Cancer vol. 71, (5) 800-809.
10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B
Howe GR, Aronson KJ, Benito E, Castelleto R, Cornée J, Duffy S, Gallagher RP, Iscovich JM et al.(1997). The relationships between dietary fat intake and risk of colorectal cancer: Evidence from the combined analysis of 13 case-control studies. Cancer Causes and Control vol. 8, (2) 215-228.
10.1023/A:1018476414781
Bashir SA, Duffy SW, Qizilbash N(1997). Repeat measurement of case-control data: Corrections for measurement error in a study of ischaemic stroke and haemostatic factors. International Journal of Epidemiology vol. 26, (1) 64-70.
10.1093/ije/26.1.64
Warren RML, Duffy S(1997). A comparison of the effectiveness of 28 kV (grid) versus 25 kV (no grid) mammographic techniques for breast screening. British Journal of Radiology vol. 70, (OCT.) 1022-1027.
10.1259/bjr.70.838.9404206
Chen HH, Duffy SW, Tabar L(1997). A mover-stayer mixture of Markov chain models for the assessment of dedifferentiation and tumour progression in breast cancer. Journal of Applied Statistics vol. 24, (3) 265-278.
10.1080/02664769723675
Duffy SW, Day NE, Tabár L, Chen HH, Smith TC(1997). Markov models of breast tumor progression: some age-specific results. Journal of the National Cancer Institute. Monographs (22) 93-97.
10.1093/jncimono/1997.22.93
Tabár L, Chen HH, Fagerberg G, Duffy SW, Smith TC(1997). Recent results from the Swedish Two-County Trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening. Journal of the National Cancer Institute. Monographs (22) 43-47.
10.1093/jncimono/1997.22.43
Bjurstam N, Björneld L, Duffy SW, Smith TC, Cahlin E, Erikson O, Lingaas H, Mattsson J et al.(1997). The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49. Journal of the National Cancer Institute. Monographs (22) 53-55.
10.1093/jncimono/1997.22.53
Bashir SA, Duffy SW(1997). The correction of risk estimates for measurement error. Annals of Epidemiology vol. 7, (2) 154-164.
10.1016/S1047-2797(96)00149-4
Qizilbash N, Duffy S, Prentice CRM, Boothby M, Warlow C(1997). Von Willebrand factor and risk of ischemic stroke. Neurology vol. 49, (6) 1552-1556.
10.1212/WNL.49.6.1552
Calle EE, Heath CW, Miracle-McMahill HL, Coates RJ, Liff JM, Franceschi S, Talamini R, Chantarakul N et al.(1996). Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet vol. 347, (9017) 1713-1727.
10.1016/S0140-6736(96)90806-5
Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A(1996). Tumour development, histology and grade of breast cancers: Prognosis and progression. International Journal of Cancer vol. 66, (4) 413-419.
10.1002/(SICI)1097-0215(19960516)66:4<413::AID-IJC1>3.0.CO;2-Z
Seow A, Duffy SW, McGee MA, Lee J, Lee HP(1996). Breast cancer in Singapore: Trends in incidence 1968-1992. International Journal of Epidemiology vol. 25, (1) 40-45.
10.1093/ije/25.1.40
Chen HH, Duffy SW, Tabar L(1996). A Markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening. Journal of the Royal Statistical Society Series D: The Statistician vol. 45, (3) 307-317.
10.2307/2988469
Tabár L, Duffy SW, Chen HH(1996). Re: Quantitative interpretation of age-specific mortality reductions from the Swedish Breast Cancer-Screening Trials. Journal of the National Cancer Institute vol. 88, (1) 52-55.
10.1093/jnci/88.1.52-a
Duffy SW, Chen HH, Tabar L, Fagerberg G, Paci E(1996). Sojourn time, sensitivity and positiva predictive value of mammography screening for breast cancer in women aged 40-49. International Journal of Epidemiology vol. 25, (6) 1139-1145.
10.1093/ije/25.6.1139
Warren RML, Duffy SW, Bashir S(1996). The value of the second view in screening mammography. British Journal of Radiology vol. 69, (818) 105-108.
10.1259/0007-1285-69-818-105
Day NE, Duffy SW(1996). Trial design based on surrogate end points - Application to comparison of different breast screening frequencies. Journal of the Royal Statistical Society. Series A: Statistics in Society vol. 159, (1) 49-60.
10.2307/2983468
Qizilbash N, Lewington S, Duffy S, Peto R(1995). Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts. Lancet vol. 346, (8991-8992) 1647-1653.
10.1016/s0140-6736(95)92836-7
Duffy SW, Tabar L(1995). Screening for breast cancer. The Lancet vol. 346, (8978)
10.1016/S0140-6736(95)91674-1
Cheng KK, Duffy SW, Day NE, Lam TH, Chung SF, Badrinath P(1995). Stopping drinking and risk of oesophageal cancer. BMJ vol. 310, (6987)
10.1136/bmj.310.6987.1094
Paci E, Alexander FE, Anderson TJ, Hakama M, Thornton H, Day NE, Tabar L, Duffy SW et al.(1995). Population breast-cancer screening. The Lancet vol. 345, (8953) 853-855.
10.1016/S0140-6736(95)92988-6
Warren RML, Duffy SW(1995). Comparison of single reading with double reading of mammograms, and change in effectiveness with experience. British Journal of Radiology vol. 68, (813) 958-962.
10.1259/0007-1285-68-813-958
Bashir SA, Duffy SW(1995). Correction of risk estimates for measurement error in epidemiology. Methods of Information in Medicine vol. 34, (5) 503-510.
10.1055/s-0038-1634621
Chen HH, Tabar L, Fagerberg G, Duffy SW(1995). Effect of breast cancer screening after age 65. Journal of Medical Screening vol. 2, (1) 10-14.
10.1177/096914139500200104
Tabar L, Fagerberg G, Chen H, Duffy SW, Smart CR, Gad A, Smith RA(1995). Efficacy of breast cancer screening by age. New results swedish two‐county trial. Cancer vol. 75, (10) 2507-2517.
10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H
Duffy SW, Chen H, Tabar L, Day NE(1995). Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Statistics in Medicine vol. 14, (14) 1531-1543.
10.1002/sim.4780141404
Andrieu N, Duffy SW, Rohan TE, Lê MG, Luporsi E, Gerber M, Renaud R, Zaridze DG et al.(1995). Familial risk, abortion and their interactive effect on the risk of breast cancer - a combined analysis of six case-control studies. British Journal of Cancer vol. 72, (3) 744-751.
10.1038/bjc.1995.404
Estéve J, Parker L, Roy P, Herrmann F, Duffy S, Frappaz D, Lasset C, Hill C et al.(1995). Is neuroblastoma screening evaluation needed and feasible?. British Journal of Cancer vol. 71, (6) 1125-1131.
10.1038/bjc.1995.219
Day N, Mccann J, Camilleri-Ferrante C, Cush S, Duffy S, Hurst G, Britton P(1995). Monitoring interval cancers in breast screening programmes: The East Anglian experience. Journal of Medical Screening vol. 2, (4) 180-185.
10.1177/096914139500200402
Cheng KK, Duffy SW, Day NE, Lam TH(1995). Oesophageal cancer in never‐smokers and never‐drinkers. International Journal of Cancer vol. 60, (6) 820-822.
10.1002/ijc.2910600616
Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A(1995). Screening for breast cancer in women aged under 50: Mode of detection, incidence, fatality, and histology. Journal of Medical Screening vol. 2, (2) 94-98.
10.1177/096914139500200208
Fleming T, Day NE, Duffy SW, Tabar L(1995). Surrogate markers in aids and cancer trials. Statistics in Medicine vol. 14, (23) 2619-2620.
10.1002/sim.4780142310
Day NE, Duffy SW, Chen H(1995). Survival and Interim End Points in Breast Cancer. Journal of Medical Screening vol. 2, (1) 57-58.
10.1177/096914139500200118
Duffy SW(1994). Risk-factor epidemiology. Lancet vol. 343, (8894)
10.1016/S0140-6736(94)91258-0
Sankaranarayanan R, Varghese C, Duffy SW, Padmakumary G, Day NE, Nair MK(1994). A case‐control study of diet and lung cancer in Kerala, South India. International Journal of Cancer vol. 58, (5) 644-649.
10.1002/ijc.2910580505
Duffy SW, Rohan TE, McLaughlin JR(1994). Design and analysis considerations in a cohort study involving repeated measurement of both exposure and outcome: The association between genital papillomavirus infection and risk of cervical intraepithelial neoplasia. Statistics in Medicine vol. 13, (4) 379-390.
10.1002/sim.4780130405
Ewertz M, Duffy SW(1994). Incidence of female breast cancer in relation to prevalence of risk factors in Denmark. International Journal of Cancer vol. 56, (6) 783-787.
10.1002/ijc.2910560604
Duffy SW, Sharples LD(1994). Misinterpretation of published results. Addiction vol. 89, (6) 756-759.
10.1111/j.1360-0443.1994.tb00962.x
Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE(1994). Preserved foods and nasopharyngeal carcinoma: A case‐control study among singapore chinese. International Journal of Cancer vol. 59, (5) 585-590.
10.1002/ijc.2910590502
Zaridze DG, Marochko A, Basieva T, Duffy SW(1993). Cancer incidence in the native peoples of far eastern siberia. International Journal of Cancer vol. 54, (6) 889-894.
10.1002/ijc.2910540602
Zaridze D, Filipchenko V, Kustov V, Serdyuk V, Duffy S(1993). Diet and colorectal cancer: Results of two case-control studies in Russia. European Journal of Cancer vol. 29, (1) 112-115.
10.1016/0959-8049(93)90586-5
Tabar L, Duffy SW, Burhenne LW(1993). New swedish breast cancer detection results for women aged 40–49. Cancer vol. 72, (4 S) 1437-1448.
10.1002/1097-0142(19930815)72:4+<1437::AID-CNCR2820721405>3.0.CO;2-M
Zaridze DG, Arkadieva MA, Day NE, Duffy SW(1993). Risk of leukaemia after chemotherapy in a case-control study in Moscow. British Journal of Cancer vol. 67, (2) 347-350.
10.1038/bjc.1993.63
Lee HP, Gourley L, Duffy SW, Estève J, Lee J, Day NE(1992). Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes and Control vol. 3, (4) 313-322.
10.1007/BF00146884
Cheng KK, Lam TH, Cheng KK, Day NE, Day NE, Duffy SW, Fok M, Wong J(1992). Pickled vegetables in the aetiology of oesophageal cancer in Hong Kong Chinese. The Lancet vol. 339, (8805) 1314-1318.
10.1016/0140-6736(92)91960-G
Tabár L, Fagerberg G, Day NE, Duffy SW, Kitchin RM(1992). Breast cancer treatment and natural history: new insights from results of screening. The Lancet vol. 339, (8790) 412-414.
10.1016/0140-6736(92)90090-P
Duffy SW, South MC, Day NE(1992). Cluster randomization in large public health trials: The importance of antecedent data. Statistics in Medicine vol. 11, (3) 307-316.
10.1002/sim.4780110304
Duffy SW, Maximovitch DM, Day NE(1992). External validation, repeat determination, and precision of risk estimation in misclassified exposure data in epidemiology. Journal of Epidemiology and Community Health vol. 46, (6) 620-624.
10.1136/jech.46.6.620
Qizilbash N, Duffy SW, Warlow C, Mann J(1992). Lipids are risk factors for ischaemic stroke: Overview and review. Cerebrovascular Diseases vol. 2, (3) 127-136.
10.1159/000109004
Zaridze DG, Basieva T, Kabulov M, Day NE, Duffy SW(1992). Oesophageal cancer in the Republic of Karakalpakstan. International Journal of Epidemiology vol. 21, (4) 643-648.
10.1093/ije/21.4.643
Zaridze D, Mukeria A, Duffy SW(1992). Risk factors for skin melanoma in Moscow. International Journal of Cancer vol. 52, (1) 159-161.
10.1002/ijc.2910520128
Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O(1992). Update of the Swedish two-county program of mammographic screening for breast cancer. Radiologic Clinics of North America vol. 30, (1) 187-210.
Paci E, Duffy SW(1991). Modelling the analysis of breast cancer screening programmes: Sensitivity, lead time and predictive value in the florence district programme (1975-1986). International Journal of Epidemiology vol. 20, (4) 852-858.
10.1093/ije/20.4.852
Lee HP, Lee J, Gourley L, Duffy SW, Day NE, Estève J(1991). Dietary effects on breast-cancer risk in Singapore. The Lancet vol. 337, (8751) 1197-1200.
10.1016/0140-6736(91)92867-2
Qizilbash N, Duffy SW, Rohan TE(1991). Repeat measurement of case-control data: Correcting risk estimates for misclassification due to regression dilution of lipids in transient ischemic attacks and minor ischemic strokes. American Journal of Epidemiology vol. 133, (8) 832-838.
10.1093/oxfordjournals.aje.a115963
Duffy SW, Tabar L, Fagerberg G, Gad A, Gröntoft O, South MC, Day NE(1991). Breast screening, prognostic factors and survival - Results from the swedish two county study. British Journal of Cancer vol. 64, (6) 1133-1138.
10.1038/bjc.1991.477
Zaridze D, Lifanova Y, Maximovitch D, Day NE, Duffy SW(1991). Diet, alcohol consumption and reproductive factors in a case‐control study of breast cancer in Moscow. International Journal of Cancer vol. 48, (4) 493-501.
10.1002/ijc.2910480404
Sankaranarayanan R, Duffy SW, Padmakumary G, Nair SM, Day NE, Padmanabhan TK(1991). Risk factors for cancer of the oesophagus in Kerala, India. International Journal of Cancer vol. 49, (4) 485-489.
10.1002/ijc.2910490402
Tabár L, Fagerberg G, Day NE, Duffy SW(1991). The Swedish two-county trial of mammographic screening for breast cancer: recent results on mortality and tumor characteristics. Pathologie-biologie vol. 39, (9)
Tabár L, Fagerberg G, Duffy SW, Day NE(1990). The WE project: mammography significantly decreases breast cancer mortality. Lakartidningen vol. 87, (1-2) 36-39.
Negri E, La Vecchia C, Duffy SW, Bruzzi P, Parazzini F, Day NE(1990). Age at first and second births and breast cancer risk in biparous women. International Journal of Cancer vol. 45, (3) 428-430.
10.1002/ijc.2910450308
Ewertz M, Duffy SW, Adami H, Kvåle G, Lund E, Meirik O, Mellemgaard A, Soini I et al.(1990). Age at first birth, parity and risk of breast cancer: A meta‐analysis of 8 studies from the nordic countries. International Journal of Cancer vol. 46, (4) 597-603.
10.1002/ijc.2910460408
Sankaranarayanan R, Duffy SW, Padmakumary G, Day NE, Nair MK(1990). Risk factors for cancer of the buccal and labial mucosa in Kerala, southern India. Journal of Epidemiology and Community Health vol. 44, (4) 286-292.
10.1136/jech.44.4.286
Tabar L, Duffy SW, Day NE(1990). Screening with mammography. International Journal of Technology Assessment in Health Care vol. 6, (3) 498-499.
10.1017/S0266462300001082
Duffy SW, Rohan TE, Altman DG(1990). The authors reply. American Journal of Epidemiology vol. 132, (1) 198-199.
10.1093/oxfordjournals.aje.a115636
Sankaranarayanan R, Duffy SW, Nair MK, Padmakumary G, Day NE(1990). Tobacco and alcohol as risk factors in cancer of the larynx in Kerala, India. International Journal of Cancer vol. 45, (5) 879-882.
10.1002/ijc.2910450517
Sankaranarayanan R, Duffy SW, Day NE, Nair MK, Padmakumary G(1989). A case‐control investigation of cancer of the oral tongue and the floor of the mouth in Southern India. International Journal of Cancer vol. 44, (4) 617-621.
10.1002/ijc.2910440410
Duffy SW, Rohan TE, Altman DG(1989). A method for combining matched and unmatched binary data: Application to randomized, controlled trials of photocoagulation in the treatment of diabetic retinopathy. American Journal of Epidemiology vol. 130, (2) 371-378.
10.1093/oxfordjournals.aje.a115343
Lee HP, Gourley L, Duffy SW, Estève J, Lee J, Day NE(1989). Colorectal cancer and diet in an asian population—A case‐control study among Singapore Chinese. International Journal of Cancer vol. 43, (6) 1007-1016.
10.1002/ijc.2910430609
Tabár L, Duffy S(1989). Malmö mammographic screening trial. BMJ (Clinical research ed.) vol. 298, (6665) 48-49.
10.1136/bmj.298.6665.48-d
Duffy SW, Rohan TE, Day NE(1989). Misclassification in more than one factor in a case‐control study: A combination of Mantel‐Haenszel and maximum likelihood approaches. Statistics in Medicine vol. 8, (12) 1529-1536.
10.1002/sim.4780081213
Tabar L, Fagerberg G, Duffy SW, Day NE(1989). The Swedish two county trial of mammographic screening for breast cancer: Recent results and calculation of benefit. Journal of Epidemiology and Community Health vol. 43, (2) 107-114.
10.1136/jech.43.2.107
Sankaranarayanan R, Duffy SW, Padmakumary G, Day NE, Padmanabhan TK(1989). Tobacco chewing, alcohol and nasal snuff in cancer of the gingiva in Kerala, India. British Journal of Cancer vol. 60, (4) 638-643.
10.1038/bjc.1989.330
Gourley L, Duffy SW, Lee HP, Walker AM, Day NE(1988). A survey of household food purchases and dietary habits in relation to affluence among Singapore Chinese. European Journal of Clinical Nutrition vol. 42, (4) 333-343.
Lee HP, Duffy SW, Day NE, Shanmugaratnam K(1988). Recent trends in cancer incidence among Singapore Chinese. International Journal of Cancer vol. 42, (2) 159-166.
10.1002/ijc.2910420204
Ewertz M, Duffy SW(1988). Risk of breast cancer in relation to reproductive factors in Denmark. British Journal of Cancer vol. 58, (1) 99-104.
10.1038/bjc.1988.172
Kennedy CR, Duffy SW, Smith R, Robinson RO(1987). Clinical predictors of outcome in encephalitis. Archives of Disease in Childhood vol. 62, (11) 1156-1162.
10.1136/adc.62.11.1156
Tabar L, Duffy SW, Krusemo UB(1987). Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening. European Journal of Cancer and Clinical Oncology vol. 23, (7) 959-962.
10.1016/0277-5379(87)90341-5
Duffy SW, Tabar L(1987). Screening for breast cancer. Journal of Chronic Diseases vol. 40, (9) 907-908.
10.1016/0021-9681(87)90192-5
Stephens S, Duffy SW, Page C(1986). A longitudinal study of γ-interferon production by peripheral blood mononuclear cells from breast- and bottle-fed infants. Clinical and Experimental Immunology vol. 65, (2) 396-400.
Stephens S, Brenner MK, Duffy SW, Lakhani PK, Kennedy CR, Farrant J(1986). The effect of breast-feeding on proliferation by infant lymphocytes in vitro. Pediatric Research vol. 20, (3) 227-231.
10.1203/00006450-198603000-00006
Armstrong CP, Dixon JM, Duffy SW, Elton RA, Taylor TV, Davies GC(1985). Choledochotomy and sepsis in benign biliary disease. Journal of the Royal College of Surgeons of Edinburgh vol. 30, (6) 343-347.
Levy M, Parmar M, Coetzee D, Duffy SW(1985). Respiratory consultations in asthmatic compared with non-asthmatic children in general practice. British medical journal (Clinical research ed.) vol. 291, (6487) 29-30.
10.1136/bmj.291.6487.29
Dixon JM, Armstrong CP, Duffy SW, Chetty U, Davies GC(1984). A randomized prospective trial comparing the value of intravenous and preincisional cefamandole in reducing postoperative sepsis after operations upon the gastrointestinal tract. Surgery Gynecology and Obstetrics vol. 158, (4) 303-307.
Dixon JM, Armstrong CP, Duffy SW, Elton RA, Davies GC(1984). Factors affecting mortality and morbidity after surgery for obstructive jaundice. Gut vol. 25, (1)
10.1136/gut.25.1.104
Muir BB, Kirkpatrick AE, Roberts MM, Duffy SW(1984). Oblique-view mammography: Adequacy for screening. Work in progress. Radiology vol. 151, (1) 39-41.
10.1148/radiology.151.1.6701330
Hickman RE, Cawson RA, Duffy SW(1984). The prognosis of specific types of salivary gland tumors. Cancer vol. 54, (8) 1620-1624.
10.1002/1097-0142(19841015)54:8<1620::AID-CNCR2820540824>3.0.CO;2-I
Dixon JM, Armstrong CP, Duffy SW, Elton RA, Davies GC(1984). Upper gastrointestinal bleeding. A significant complication after surgery for relief of obstructive jaundice. Annals of Surgery vol. 199, (3) 271-275.
10.1097/00000658-198403000-00004
Armstrong CP, Dixon JM, Duffy SW, Elton RA, Davies GC(1984). Wound healing in obstructive jaundice. British Journal of Surgery vol. 71, (4) 267-270.
10.1002/bjs.1800710405
Dixon JM, Armstrong CP, Duffy SW(1983). A randomized prospective trial of preincisional and intravenous cefamandole in the prevention of post operative sepsis in patients undergoing abdominal surgery. Scottish Medical Journal vol. 28, (1)
Elton RA, Duffy SW(1983). Correcting for the effect of misclassification bias in a case-control study using data from two different questionnaires. Biometrics vol. 39, (3) 659-663.
10.2307/2531093
Dixon JM, Armstrong CP, Duffy SW, Davies GC(1983). Factors affecting morbidity and mortality after surgery for obstructive jaundice: A review of 373 patients. Gut vol. 24, (9) 845-852.
10.1136/gut.24.9.845
Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW, Stewart HJ(1983). Infiltrating lobular carcinoma of the breast: An evaluation of the incidence and consequence of bilateral disease. British Journal of Surgery vol. 70, (9) 513-516.
10.1002/bjs.1800700902
Duffy SW, Roberts MM, Elton RA(1983). Risk factors for breast cancer: Relevance to screening. Journal of Epidemiology and Community Health vol. 37, (2) 127-131.
10.1136/jech.37.2.127
Duffy SW, Roberts MM, Elton RA(1983). Risk factors relevant to cystic breast disease: A case-control study. Journal of Epidemiology and Community Health vol. 37, (4) 271-273.
10.1136/jech.37.4.271
Dixon JM, Anderson TJ, Page DL, Lee D, Duffy SW(1982). Authors' reply. Histopathology vol. 6, (6) 816-817.
10.1111/j.1365-2559.1982.tb02779.x
DIXON JM, ANDERSON TJ, PAGE DL, LEE D, DUFFY SW(1982). Infiltrating lobular carcinoma of the breast. Histopathology vol. 6, (2) 149-161.
10.1111/j.1365-2559.1982.tb02712.x
Return to top